Frequencies for first 10,000 rows of pt variable in reac2011q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 9 0.09 0.09 ABDOMINAL ABSCESS | 2 0.02 0.11 ABDOMINAL ADHESIONS | 1 0.01 0.12 ABDOMINAL DISCOMFORT | 22 0.22 0.34 ABDOMINAL DISTENSION | 13 0.13 0.47 ABDOMINAL HERNIA | 2 0.02 0.49 ABDOMINAL MASS | 1 0.01 0.50 ABDOMINAL OPERATION | 1 0.01 0.51 ABDOMINAL PAIN | 53 0.53 1.04 ABDOMINAL PAIN LOWER | 5 0.05 1.09 ABDOMINAL PAIN UPPER | 44 0.44 1.53 ABDOMINAL RIGIDITY | 1 0.01 1.54 ABDOMINAL WALL HAEMORRHAGE | 2 0.02 1.56 ABNORMAL BEHAVIOUR | 8 0.08 1.64 ABNORMAL DREAMS | 6 0.06 1.70 ABNORMAL LOSS OF WEIGHT | 3 0.03 1.73 ABNORMAL SENSATION IN EYE | 3 0.03 1.76 ABORTION | 1 0.01 1.77 ABORTION INDUCED | 5 0.05 1.82 ABORTION SPONTANEOUS | 11 0.11 1.93 ABSCESS | 2 0.02 1.95 ABSCESS INTESTINAL | 1 0.01 1.96 ABSCESS LIMB | 1 0.01 1.97 ACANTHOSIS | 2 0.02 1.99 ACCELERATED HYPERTENSION | 1 0.01 2.00 ACCIDENT | 5 0.05 2.05 ACCIDENT AT WORK | 1 0.01 2.06 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 2.07 ACCIDENTAL OVERDOSE | 4 0.04 2.11 ACIDOSIS | 3 0.03 2.14 ACINETOBACTER INFECTION | 1 0.01 2.15 ACNE | 4 0.04 2.19 ACQUIRED DIAPHRAGMATIC EVENTRATION | 1 0.01 2.20 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 1 0.01 2.21 ACTIVITIES OF DAILY LIVING IMPAIRED | 5 0.05 2.26 ACUTE CORONARY SYNDROME | 2 0.02 2.28 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 8 0.08 2.36 ACUTE GRAFT VERSUS HOST DISEASE | 1 0.01 2.37 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 1 0.01 2.38 ACUTE HEPATIC FAILURE | 1 0.01 2.39 ACUTE LEUKAEMIA | 1 0.01 2.40 ACUTE LYMPHOCYTIC LEUKAEMIA | 1 0.01 2.41 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT | 1 0.01 2.42 ACUTE MYELOID LEUKAEMIA | 15 0.15 2.57 ACUTE MYOCARDIAL INFARCTION | 6 0.06 2.63 ACUTE PROMYELOCYTIC LEUKAEMIA | 1 0.01 2.64 ACUTE PULMONARY OEDEMA | 2 0.02 2.66 ACUTE RESPIRATORY DISTRESS SYNDROME | 3 0.03 2.69 ACUTE RESPIRATORY FAILURE | 5 0.05 2.74 ADENOCARCINOMA OF THE CERVIX | 1 0.01 2.75 ADENOCARCINOMA PANCREAS | 1 0.01 2.76 ADENOMATOUS POLYPOSIS COLI | 1 0.01 2.77 ADENOVIRUS INFECTION | 1 0.01 2.78 ADMINISTRATION RELATED REACTION | 1 0.01 2.79 ADRENAL NEOPLASM | 1 0.01 2.80 ADVERSE DRUG REACTION | 4 0.04 2.84 ADVERSE EVENT | 10 0.10 2.94 AFFECTIVE DISORDER | 1 0.01 2.95 AGEUSIA | 1 0.01 2.96 AGGRESSION | 7 0.07 3.03 AGITATION | 11 0.11 3.14 AGRANULOCYTOSIS | 3 0.03 3.17 AKATHISIA | 2 0.02 3.19 ALANINE AMINOTRANSFERASE INCREASED | 22 0.22 3.41 ALCOHOLISM | 2 0.02 3.43 ALOPECIA | 8 0.08 3.51 ALTERED STATE OF CONSCIOUSNESS | 6 0.06 3.57 ALVEOLITIS | 2 0.02 3.59 AMENORRHOEA | 4 0.04 3.63 AMMONIA INCREASED | 1 0.01 3.64 AMNESIA | 11 0.11 3.75 AMYLOIDOSIS | 1 0.01 3.76 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 3.77 ANAEMIA | 48 0.48 4.25 ANAEMIA MEGALOBLASTIC | 1 0.01 4.26 ANAL ULCER | 1 0.01 4.27 ANAPHYLACTIC REACTION | 7 0.07 4.34 ANAPHYLACTIC SHOCK | 13 0.13 4.47 ANGER | 6 0.06 4.53 ANGINA PECTORIS | 10 0.10 4.63 ANGINA UNSTABLE | 3 0.03 4.66 ANGIOEDEMA | 14 0.14 4.80 ANGIOPATHY | 4 0.04 4.84 ANGLE CLOSURE GLAUCOMA | 2 0.02 4.86 ANHEDONIA | 2 0.02 4.88 ANION GAP INCREASED | 1 0.01 4.89 ANKLE FRACTURE | 5 0.05 4.94 ANORECTAL DISORDER | 1 0.01 4.95 ANOSMIA | 1 0.01 4.96 ANTICONVULSANT DRUG LEVEL ABNORMAL | 1 0.01 4.97 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 4.98 ANTIDEPRESSANT DRUG LEVEL INCREASED | 1 0.01 4.99 ANTINUCLEAR ANTIBODY POSITIVE | 1 0.01 5.00 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAP.. | 1 0.01 5.01 ANURIA | 1 0.01 5.02 ANXIETY | 52 0.52 5.54 AORTIC ANEURYSM | 1 0.01 5.55 AORTIC ANEURYSM RUPTURE | 1 0.01 5.56 AORTIC ARTERIOSCLEROSIS | 1 0.01 5.57 AORTIC DISSECTION | 1 0.01 5.58 AORTIC RUPTURE | 1 0.01 5.59 AORTIC STENOSIS | 3 0.03 5.62 AORTIC VALVE INCOMPETENCE | 2 0.02 5.64 APHAGIA | 2 0.02 5.66 APHASIA | 8 0.08 5.74 APHONIA | 3 0.03 5.77 APHTHOUS STOMATITIS | 4 0.04 5.81 APLASIA PURE RED CELL | 3 0.03 5.84 APNOEA | 5 0.05 5.89 APOLIPOPROTEIN A-I DECREASED | 3 0.03 5.92 APPARENT DEATH | 1 0.01 5.93 APPENDICECTOMY | 1 0.01 5.94 APPENDICITIS | 1 0.01 5.95 APPENDICITIS PERFORATED | 1 0.01 5.96 APPLICATION SITE BLEEDING | 1 0.01 5.97 APPLICATION SITE ERYTHEMA | 3 0.03 6.00 APPLICATION SITE EXFOLIATION | 1 0.01 6.01 APPLICATION SITE IRRITATION | 2 0.02 6.03 APPLICATION SITE PRURITUS | 3 0.03 6.06 APPLICATION SITE RASH | 1 0.01 6.07 APPLICATION SITE REACTION | 1 0.01 6.08 APPLICATION SITE SWELLING | 1 0.01 6.09 APPLICATION SITE URTICARIA | 1 0.01 6.10 APPLICATION SITE VESICLES | 1 0.01 6.11 APRAXIA | 1 0.01 6.12 AREFLEXIA | 1 0.01 6.13 ARNOLD-CHIARI MALFORMATION | 1 0.01 6.14 ARRESTED LABOUR | 1 0.01 6.15 ARRHYTHMIA | 5 0.05 6.20 ARTERIAL HAEMORRHAGE | 1 0.01 6.21 ARTERIAL OCCLUSIVE DISEASE | 2 0.02 6.23 ARTERIAL STENT INSERTION | 1 0.01 6.24 ARTERIAL THROMBOSIS | 1 0.01 6.25 ARTERIOSCLEROSIS | 6 0.06 6.31 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 6.32 ARTERIOSPASM CORONARY | 1 0.01 6.33 ARTHRALGIA | 46 0.46 6.79 ARTHRITIS | 6 0.06 6.85 ARTHRITIS BACTERIAL | 1 0.01 6.86 ARTHROPATHY | 15 0.15 7.01 ARTHROPOD STING | 1 0.01 7.02 ARTICULAR CALCIFICATION | 1 0.01 7.03 ASCITES | 9 0.09 7.12 ASPARTATE AMINOTRANSFERASE ABNORMAL | 1 0.01 7.13 ASPARTATE AMINOTRANSFERASE INCREASED | 16 0.16 7.29 ASPHYXIA | 1 0.01 7.30 ASPIRATION | 2 0.02 7.32 ASPIRATION PLEURAL CAVITY | 1 0.01 7.33 ASTHENIA | 68 0.68 8.01 ASTHMA | 20 0.20 8.21 ATAXIA | 2 0.02 8.23 ATELECTASIS | 8 0.08 8.31 ATRIAL FIBRILLATION | 13 0.13 8.44 ATRIAL FLUTTER | 3 0.03 8.47 ATRIAL SEPTAL DEFECT | 12 0.12 8.59 ATRIOVENTRICULAR BLOCK | 4 0.04 8.63 ATRIOVENTRICULAR BLOCK COMPLETE | 4 0.04 8.67 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 2 0.02 8.69 ATROPHY | 1 0.01 8.70 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 8.71 AUTOIMMUNE DISORDER | 1 0.01 8.72 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 8.73 AZOTAEMIA | 1 0.01 8.74 BACK DISORDER | 2 0.02 8.76 BACK PAIN | 39 0.39 9.15 BACTERAEMIA | 1 0.01 9.16 BACTERIAL INFECTION | 4 0.04 9.20 BACTERIURIA IN PREGNANCY | 1 0.01 9.21 BALANCE DISORDER | 17 0.17 9.38 BALANITIS | 1 0.01 9.39 BASAL CELL CARCINOMA | 4 0.04 9.43 BASAL GANGLIA INFARCTION | 1 0.01 9.44 BEDRIDDEN | 2 0.02 9.46 BEHCET'S SYNDROME | 2 0.02 9.48 BENCE JONES PROTEINURIA | 1 0.01 9.49 BENIGN INTRACRANIAL HYPERTENSION | 1 0.01 9.50 BENIGN NEOPLASM | 1 0.01 9.51 BENIGN OVARIAN TUMOUR | 1 0.01 9.52 BENIGN PROSTATIC HYPERPLASIA | 2 0.02 9.54 BICUSPID AORTIC VALVE | 1 0.01 9.55 BILE DUCT STONE | 1 0.01 9.56 BILIARY COLIC | 5 0.05 9.61 BILIARY DYSKINESIA | 7 0.07 9.68 BILIARY NEOPLASM | 1 0.01 9.69 BINOCULAR EYE MOVEMENT DISORDER | 1 0.01 9.70 BIOPSY BONE MARROW ABNORMAL | 1 0.01 9.71 BIPOLAR I DISORDER | 1 0.01 9.72 BITE | 1 0.01 9.73 BK VIRUS INFECTION | 1 0.01 9.74 BLADDER CANCER | 3 0.03 9.77 BLADDER MASS | 1 0.01 9.78 BLADDER OPERATION | 1 0.01 9.79 BLEEDING TIME PROLONGED | 2 0.02 9.81 BLINDNESS | 9 0.09 9.90 BLINDNESS UNILATERAL | 4 0.04 9.94 BLISTER | 8 0.08 10.02 BLOOD ALBUMIN DECREASED | 3 0.03 10.05 BLOOD ALKALINE PHOSPHATASE INCREASED | 6 0.06 10.11 BLOOD AMYLASE INCREASED | 2 0.02 10.13 BLOOD BICARBONATE ABNORMAL | 1 0.01 10.14 BLOOD BICARBONATE DECREASED | 1 0.01 10.15 BLOOD BILIRUBIN INCREASED | 8 0.08 10.23 BLOOD CALCIUM DECREASED | 1 0.01 10.24 BLOOD CALCIUM INCREASED | 3 0.03 10.27 BLOOD CHLORIDE DECREASED | 1 0.01 10.28 BLOOD CHOLESTEROL DECREASED | 1 0.01 10.29 BLOOD CHOLESTEROL INCREASED | 8 0.08 10.37 BLOOD COUNT ABNORMAL | 5 0.05 10.42 BLOOD CREATINE PHOSPHOKINASE INCREASED | 10 0.10 10.52 BLOOD CREATININE INCREASED | 28 0.28 10.80 BLOOD DISORDER | 3 0.03 10.83 BLOOD GLUCOSE ABNORMAL | 3 0.03 10.86 BLOOD GLUCOSE DECREASED | 4 0.04 10.90 BLOOD GLUCOSE FLUCTUATION | 3 0.03 10.93 BLOOD GLUCOSE INCREASED | 19 0.19 11.12 BLOOD IMMUNOGLOBULIN E INCREASED | 2 0.02 11.14 BLOOD IMMUNOGLOBULIN G INCREASED | 1 0.01 11.15 BLOOD IRON INCREASED | 1 0.01 11.16 BLOOD KETONE BODY INCREASED | 1 0.01 11.17 BLOOD LACTATE DEHYDROGENASE INCREASED | 5 0.05 11.22 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 11.23 BLOOD POTASSIUM DECREASED | 6 0.06 11.29 BLOOD POTASSIUM INCREASED | 6 0.06 11.35 BLOOD PRESSURE ABNORMAL | 7 0.07 11.42 BLOOD PRESSURE DECREASED | 15 0.15 11.57 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 11.59 BLOOD PRESSURE INCREASED | 23 0.23 11.82 BLOOD PRESSURE SYSTOLIC DECREASED | 1 0.01 11.83 BLOOD PRESSURE SYSTOLIC INCREASED | 1 0.01 11.84 BLOOD PROLACTIN INCREASED | 1 0.01 11.85 BLOOD SODIUM DECREASED | 3 0.03 11.88 BLOOD TEST ABNORMAL | 1 0.01 11.89 BLOOD THYROID STIMULATING HORMONE INC.. | 2 0.02 11.91 BLOOD TRIGLYCERIDES ABNORMAL | 1 0.01 11.92 BLOOD TRIGLYCERIDES INCREASED | 4 0.04 11.96 BLOOD UREA DECREASED | 1 0.01 11.97 BLOOD UREA INCREASED | 9 0.09 12.06 BLOOD URIC ACID INCREASED | 2 0.02 12.08 BLOOD URINE PRESENT | 3 0.03 12.11 BODY HEIGHT DECREASED | 1 0.01 12.12 BODY TEMPERATURE DECREASED | 1 0.01 12.13 BODY TEMPERATURE INCREASED | 6 0.06 12.19 BODY TINEA | 1 0.01 12.20 BONE DEBRIDEMENT | 1 0.01 12.21 BONE DENSITY DECREASED | 3 0.03 12.24 BONE DISORDER | 5 0.05 12.29 BONE EROSION | 1 0.01 12.30 BONE LESION | 3 0.03 12.33 BONE MARROW DISORDER | 1 0.01 12.34 BONE MARROW FAILURE | 5 0.05 12.39 BONE MARROW NECROSIS | 1 0.01 12.40 BONE MARROW RETICULIN FIBROSIS | 2 0.02 12.42 BONE NEOPLASM | 1 0.01 12.43 BONE PAIN | 15 0.15 12.58 BONE SARCOMA | 1 0.01 12.59 BONE TUBERCULOSIS | 1 0.01 12.60 BOVINE TUBERCULOSIS | 3 0.03 12.63 BRADYCARDIA | 15 0.15 12.78 BRADYKINESIA | 1 0.01 12.79 BRADYPHRENIA | 2 0.02 12.81 BRAIN INJURY | 1 0.01 12.82 BRAIN NATRIURETIC PEPTIDE INCREASED | 1 0.01 12.83 BRAIN NEOPLASM | 3 0.03 12.86 BRAIN NEOPLASM MALIGNANT | 1 0.01 12.87 BRAIN OEDEMA | 2 0.02 12.89 BRAIN OPERATION | 1 0.01 12.90 BREAST ABSCESS | 1 0.01 12.91 BREAST CANCER | 11 0.11 13.02 BREAST CANCER FEMALE | 29 0.29 13.31 BREAST CANCER IN SITU | 1 0.01 13.32 BREAST CANCER METASTATIC | 7 0.07 13.39 BREAST CANCER RECURRENT | 1 0.01 13.40 BREAST DISCHARGE | 2 0.02 13.42 BREAST ENLARGEMENT | 3 0.03 13.45 BREAST HYPERPLASIA | 1 0.01 13.46 BREAST INFLAMMATION | 1 0.01 13.47 BREAST MASS | 1 0.01 13.48 BREAST MILK DISCOLOURATION | 1 0.01 13.49 BREAST OPERATION | 1 0.01 13.50 BREAST PAIN | 2 0.02 13.52 BREAST RECONSTRUCTION | 1 0.01 13.53 BREAST TENDERNESS | 3 0.03 13.56 BREATH ODOUR | 5 0.05 13.61 BRONCHIAL CARCINOMA | 1 0.01 13.62 BRONCHIAL DISORDER | 1 0.01 13.63 BRONCHIAL IRRITATION | 1 0.01 13.64 BRONCHIECTASIS | 1 0.01 13.65 BRONCHITIS | 19 0.19 13.84 BRONCHOPNEUMONIA | 5 0.05 13.89 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 13.90 BRONCHOPULMONARY DYSPLASIA | 1 0.01 13.91 BRONCHOSPASM | 5 0.05 13.96 BUNDLE BRANCH BLOCK | 1 0.01 13.97 BUNDLE BRANCH BLOCK RIGHT | 1 0.01 13.98 BURNING MOUTH SYNDROME | 1 0.01 13.99 BURNING SENSATION | 10 0.10 14.09 BURSITIS | 9 0.09 14.18 C-REACTIVE PROTEIN INCREASED | 15 0.15 14.33 CACHEXIA | 1 0.01 14.34 CAESAREAN SECTION | 1 0.01 14.35 CAFFEINE CONSUMPTION | 1 0.01 14.36 CALCIPHYLAXIS | 1 0.01 14.37 CALCULUS URINARY | 1 0.01 14.38 CANDIDA SEPSIS | 1 0.01 14.39 CANDIDIASIS | 6 0.06 14.45 CANDIDURIA | 1 0.01 14.46 CARBOHYDRATE ANTIGEN 19-9 INCREASED | 2 0.02 14.48 CARCINOEMBRYONIC ANTIGEN INCREASED | 2 0.02 14.50 CARCINOID SYNDROME | 1 0.01 14.51 CARCINOID TUMOUR | 1 0.01 14.52 CARDIAC ARREST | 32 0.32 14.84 CARDIAC DISORDER | 19 0.19 15.03 CARDIAC FAILURE | 22 0.22 15.25 CARDIAC FAILURE ACUTE | 1 0.01 15.26 CARDIAC FAILURE CONGESTIVE | 33 0.33 15.59 CARDIAC FIBRILLATION | 1 0.01 15.60 CARDIAC HYPERTROPHY | 1 0.01 15.61 CARDIAC MURMUR | 10 0.10 15.71 CARDIAC VALVE DISEASE | 2 0.02 15.73 CARDIO-RESPIRATORY ARREST | 20 0.20 15.93 CARDIOGENIC SHOCK | 1 0.01 15.94 CARDIOMEGALY | 7 0.07 16.01 CARDIOMYOPATHY | 3 0.03 16.04 CARDIOPULMONARY FAILURE | 1 0.01 16.05 CARDIOTOXICITY | 1 0.01 16.06 CARDIOVASCULAR DISORDER | 3 0.03 16.09 CARDIOVASCULAR INSUFFICIENCY | 2 0.02 16.11 CARDIOVERSION | 1 0.01 16.12 CAROTID ARTERY OCCLUSION | 1 0.01 16.13 CAROTID ARTERY STENOSIS | 1 0.01 16.14 CAROTID ARTERY THROMBOSIS | 1 0.01 16.15 CAROTID ENDARTERECTOMY | 1 0.01 16.16 CARPAL TUNNEL SYNDROME | 3 0.03 16.19 CARTILAGE ATROPHY | 1 0.01 16.20 CATARACT | 7 0.07 16.27 CATARACT CONGENITAL | 1 0.01 16.28 CATARACT OPERATION | 1 0.01 16.29 CATARACT OPERATION COMPLICATION | 1 0.01 16.30 CATHETER PLACEMENT | 2 0.02 16.32 CATHETER SITE PRURITUS | 1 0.01 16.33 CATHETERISATION CARDIAC | 2 0.02 16.35 CAUDA EQUINA SYNDROME | 1 0.01 16.36 CD4 LYMPHOCYTES INCREASED | 1 0.01 16.37 CELL DEATH | 1 0.01 16.38 CELLULITIS | 9 0.09 16.47 CELLULITIS ORBITAL | 1 0.01 16.48 CENTRAL NERVOUS SYSTEM INFECTION | 1 0.01 16.49 CENTRAL NERVOUS SYSTEM LESION | 3 0.03 16.52 CENTRAL NERVOUS SYSTEM NEOPLASM | 1 0.01 16.53 CEREBELLAR ATAXIA | 1 0.01 16.54 CEREBELLAR ATROPHY | 1 0.01 16.55 CEREBELLAR INFARCTION | 1 0.01 16.56 CEREBELLAR SYNDROME | 1 0.01 16.57 CEREBRAL ARTERY OCCLUSION | 1 0.01 16.58 CEREBRAL ASPERGILLOSIS | 1 0.01 16.59 CEREBRAL ATROPHY | 1 0.01 16.60 CEREBRAL DISORDER | 1 0.01 16.61 CEREBRAL HAEMORRHAGE | 13 0.13 16.74 CEREBRAL INFARCTION | 8 0.08 16.82 CEREBRAL ISCHAEMIA | 1 0.01 16.83 CEREBRAL PALSY | 1 0.01 16.84 CEREBRAL TOXOPLASMOSIS | 1 0.01 16.85 CEREBRAL VENOUS THROMBOSIS | 1 0.01 16.86 CEREBROVASCULAR ACCIDENT | 60 0.60 17.46 CERVICAL SPINAL STENOSIS | 1 0.01 17.47 CERVIX CARCINOMA | 1 0.01 17.48 CERVIX HAEMORRHAGE UTERINE | 1 0.01 17.49 CERVIX INFLAMMATION | 1 0.01 17.50 CHANGE OF BOWEL HABIT | 1 0.01 17.51 CHAPPED LIPS | 1 0.01 17.52 CHEST DISCOMFORT | 24 0.24 17.76 CHEST PAIN | 43 0.43 18.19 CHEST X-RAY ABNORMAL | 2 0.02 18.21 CHILLS | 23 0.23 18.44 CHOKING | 2 0.02 18.46 CHOKING SENSATION | 2 0.02 18.48 CHOLECYSTECTOMY | 9 0.09 18.57 CHOLECYSTITIS | 14 0.14 18.71 CHOLECYSTITIS ACUTE | 1 0.01 18.72 CHOLECYSTITIS CHRONIC | 12 0.12 18.84 CHOLECYSTITIS INFECTIVE | 1 0.01 18.85 CHOLELITHIASIS | 21 0.21 19.06 CHOLESTASIS | 4 0.04 19.10 CHOLESTATIC LIVER INJURY | 1 0.01 19.11 CHOLESTEROSIS | 2 0.02 19.13 CHONDROCALCINOSIS | 1 0.01 19.14 CHONDROLYSIS | 1 0.01 19.15 CHONDROPATHY | 1 0.01 19.16 CHOREA | 1 0.01 19.17 CHORIORETINOPATHY | 2 0.02 19.19 CHROMATOPSIA | 2 0.02 19.21 CHROMATURIA | 7 0.07 19.28 CHRONIC GRAFT VERSUS HOST DISEASE | 2 0.02 19.30 CHRONIC LYMPHOCYTIC LEUKAEMIA | 2 0.02 19.32 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFO.. | 1 0.01 19.33 CHRONIC MYELOID LEUKAEMIA | 1 0.01 19.34 CHRONIC MYELOMONOCYTIC LEUKAEMIA | 1 0.01 19.35 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 15 0.15 19.50 CIRCADIAN RHYTHM SLEEP DISORDER | 1 0.01 19.51 CIRCULATORY COLLAPSE | 3 0.03 19.54 CLEFT LIP | 1 0.01 19.55 CLEFT LIP AND PALATE | 1 0.01 19.56 CLEFT PALATE | 4 0.04 19.60 CLOSTRIDIAL INFECTION | 3 0.03 19.63 CLOSTRIDIUM DIFFICILE COLITIS | 4 0.04 19.67 CLOSTRIDIUM TEST POSITIVE | 1 0.01 19.68 COAGULATION TIME PROLONGED | 1 0.01 19.69 COAGULOPATHY | 5 0.05 19.74 COARCTATION OF THE AORTA | 1 0.01 19.75 COELIAC DISEASE | 2 0.02 19.77 COGNITIVE DISORDER | 6 0.06 19.83 COLD SWEAT | 1 0.01 19.84 COLECTOMY | 1 0.01 19.85 COLITIS | 7 0.07 19.92 COLITIS COLLAGENOUS | 2 0.02 19.94 COLITIS ISCHAEMIC | 3 0.03 19.97 COLITIS ULCERATIVE | 2 0.02 19.99 COLLAPSE OF LUNG | 1 0.01 20.00 COLON OPERATION | 1 0.01 20.01 COLONIC POLYP | 2 0.02 20.03 COLOSTOMY | 1 0.01 20.04 COMA | 15 0.15 20.19 COMA SCALE ABNORMAL | 1 0.01 20.20 COMPLETED SUICIDE | 34 0.34 20.54 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 20.55 COMPLICATED FRACTURE | 1 0.01 20.56 COMPLICATIONS OF TRANSPLANTED KIDNEY | 1 0.01 20.57 COMPRESSION FRACTURE | 3 0.03 20.60 COMPULSIONS | 1 0.01 20.61 COMPUTERISED TOMOGRAM ABNORMAL | 5 0.05 20.66 CONCOMITANT DISEASE AGGRAVATED | 1 0.01 20.67 CONCOMITANT DISEASE PROGRESSION | 3 0.03 20.70 CONCUSSION | 2 0.02 20.72 CONDITION AGGRAVATED | 11 0.11 20.83 CONDUCTION DISORDER | 2 0.02 20.85 CONFUSIONAL STATE | 33 0.33 21.18 CONGENITAL ANOMALY | 6 0.06 21.24 CONGENITAL AORTIC STENOSIS | 3 0.03 21.27 CONGENITAL CORONARY ARTERY MALFORMATION | 1 0.01 21.28 CONGENITAL CYSTIC KIDNEY DISEASE | 1 0.01 21.29 CONGENITAL CYSTIC LUNG | 1 0.01 21.30 CONGENITAL DIAPHRAGMATIC HERNIA | 1 0.01 21.31 CONGENITAL MUSCULOSKELETAL ANOMALY | 1 0.01 21.32 CONJUNCTIVAL HYPERAEMIA | 1 0.01 21.33 CONJUNCTIVITIS | 2 0.02 21.35 CONJUNCTIVITIS VIRAL | 1 0.01 21.36 CONSCIOUSNESS FLUCTUATING | 1 0.01 21.37 CONSTIPATION | 31 0.31 21.68 CONTUSION | 16 0.16 21.84 CONVERSION DISORDER | 1 0.01 21.85 CONVULSION | 36 0.36 22.21 COORDINATION ABNORMAL | 2 0.02 22.23 COR PULMONALE | 1 0.01 22.24 CORNEAL OEDEMA | 1 0.01 22.25 CORNEAL PERFORATION | 1 0.01 22.26 CORNEAL TRANSPLANT | 1 0.01 22.27 CORONARY ARTERY BYPASS | 1 0.01 22.28 CORONARY ARTERY DISEASE | 18 0.18 22.46 CORONARY ARTERY OCCLUSION | 3 0.03 22.49 CORONARY ARTERY STENOSIS | 1 0.01 22.50 COUGH | 49 0.49 22.99 CRANIOFACIAL DYSOSTOSIS | 1 0.01 23.00 CRANIOSYNOSTOSIS | 2 0.02 23.02 CREATININE RENAL CLEARANCE DECREASED | 2 0.02 23.04 CROHN'S DISEASE | 3 0.03 23.07 CRYING | 3 0.03 23.10 CRYPTORCHISM | 1 0.01 23.11 CSF PRESSURE INCREASED | 1 0.01 23.12 CULTURE WOUND POSITIVE | 1 0.01 23.13 CUSHING'S SYNDROME | 1 0.01 23.14 CUSHINGOID | 1 0.01 23.15 CYANOSIS | 7 0.07 23.22 CYST DRAINAGE | 1 0.01 23.23 CYSTITIS | 3 0.03 23.26 CYSTITIS HAEMORRHAGIC | 2 0.02 23.28 CYSTOID MACULAR OEDEMA | 2 0.02 23.30 CYTOLYTIC HEPATITIS | 6 0.06 23.36 CYTOMEGALOVIRUS CHORIORETINITIS | 4 0.04 23.40 CYTOMEGALOVIRUS GASTROINTESTINAL INFE.. | 1 0.01 23.41 CYTOMEGALOVIRUS INFECTION | 6 0.06 23.47 CYTOMEGALOVIRUS TEST POSITIVE | 2 0.02 23.49 CYTOTOXIC CARDIOMYOPATHY | 1 0.01 23.50 DAYDREAMING | 1 0.01 23.51 DEAFNESS | 2 0.02 23.53 DEAFNESS UNILATERAL | 1 0.01 23.54 DEATH | 214 2.14 25.68 DEATH NEONATAL | 1 0.01 25.69 DEBRIDEMENT | 1 0.01 25.70 DECEREBRATION | 1 0.01 25.71 DECREASED APPETITE | 32 0.32 26.03 DECREASED IMMUNE RESPONSIVENESS | 1 0.01 26.04 DECREASED INTEREST | 1 0.01 26.05 DECUBITUS ULCER | 4 0.04 26.09 DEEP VEIN THROMBOSIS | 32 0.32 26.41 DEFAECATION URGENCY | 1 0.01 26.42 DEHYDRATION | 32 0.32 26.74 DELIRIUM | 14 0.14 26.88 DELUSION | 2 0.02 26.90 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 26.91 DEMENTIA | 7 0.07 26.98 DENGUE FEVER | 1 0.01 26.99 DENTAL CARIES | 4 0.04 27.03 DENTAL IMPLANTATION | 1 0.01 27.04 DEPENDENCE | 3 0.03 27.07 DEPRESSED LEVEL OF CONSCIOUSNESS | 9 0.09 27.16 DEPRESSED MOOD | 9 0.09 27.25 DEPRESSION | 31 0.31 27.56 DEPRESSION SUICIDAL | 2 0.02 27.58 DEPRESSIVE SYMPTOM | 1 0.01 27.59 DERMAL CYST | 1 0.01 27.60 DERMATITIS | 1 0.01 27.61 DERMATITIS ALLERGIC | 4 0.04 27.65 DERMATITIS ATOPIC | 2 0.02 27.67 DERMATITIS BULLOUS | 3 0.03 27.70 DERMATITIS EXFOLIATIVE | 3 0.03 27.73 DERMATITIS EXFOLIATIVE GENERALISED | 1 0.01 27.74 DERMATITIS INFECTED | 1 0.01 27.75 DETOXIFICATION | 1 0.01 27.76 DEVELOPMENTAL DELAY | 1 0.01 27.77 DEVICE BREAKAGE | 6 0.06 27.83 DEVICE DISLOCATION | 5 0.05 27.88 DEVICE EXPULSION | 2 0.02 27.90 DEVICE FAILURE | 3 0.03 27.93 DEVICE LEAKAGE | 1 0.01 27.94 DEVICE MALFUNCTION | 10 0.10 28.04 DEVICE RELATED INFECTION | 1 0.01 28.05 DEXTROCARDIA | 1 0.01 28.06 DIABETES MELLITUS | 10 0.10 28.16 DIABETES MELLITUS INADEQUATE CONTROL | 3 0.03 28.19 DIABETIC COMPLICATION | 3 0.03 28.22 DIABETIC KETOACIDOSIS | 1 0.01 28.23 DIABETIC NEPHROPATHY | 1 0.01 28.24 DIABETIC NEUROPATHY | 1 0.01 28.25 DIALYSIS | 3 0.03 28.28 DIARRHOEA | 109 1.09 29.37 DIARRHOEA HAEMORRHAGIC | 6 0.06 29.43 DIASTOLIC DYSFUNCTION | 1 0.01 29.44 DIFFUSE LARGE B-CELL LYMPHOMA | 2 0.02 29.46 DILATATION VENTRICULAR | 1 0.01 29.47 DIPLOPIA | 3 0.03 29.50 DISABILITY | 6 0.06 29.56 DISBACTERIOSIS | 1 0.01 29.57 DISCOMFORT | 4 0.04 29.61 DISEASE PROGRESSION | 21 0.21 29.82 DISEASE RECURRENCE | 2 0.02 29.84 DISINHIBITION | 2 0.02 29.86 DISLOCATION OF VERTEBRA | 1 0.01 29.87 DISORIENTATION | 7 0.07 29.94 DISSEMINATED INTRAVASCULAR COAGULATION | 8 0.08 30.02 DISSEMINATED TUBERCULOSIS | 1 0.01 30.03 DISTURBANCE IN ATTENTION | 8 0.08 30.11 DIVERTICULAR PERFORATION | 1 0.01 30.12 DIVERTICULITIS | 5 0.05 30.17 DIVERTICULUM | 4 0.04 30.21 DIZZINESS | 75 0.75 30.96 DIZZINESS EXERTIONAL | 1 0.01 30.97 DNA ANTIBODY POSITIVE | 1 0.01 30.98 DOUBLE OUTLET RIGHT VENTRICLE | 1 0.01 30.99 DRUG ABUSE | 4 0.04 31.03 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 1 0.01 31.04 DRUG ADMINISTRATION ERROR | 19 0.19 31.23 DRUG DEPENDENCE | 6 0.06 31.29 DRUG DISPENSING ERROR | 2 0.02 31.31 DRUG DOSE OMISSION | 15 0.15 31.46 DRUG EFFECT DECREASED | 8 0.08 31.54 DRUG EFFECT INCREASED | 1 0.01 31.55 DRUG ERUPTION | 4 0.04 31.59 DRUG EXPOSURE DURING PREGNANCY | 108 1.08 32.67 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 32.68 DRUG HYPERSENSITIVITY | 7 0.07 32.75 DRUG INEFFECTIVE | 104 1.04 33.79 DRUG INEFFECTIVE FOR UNAPPROVED INDIC.. | 1 0.01 33.80 DRUG INTERACTION | 63 0.63 34.43 DRUG INTOLERANCE | 2 0.02 34.45 DRUG LEVEL DECREASED | 3 0.03 34.48 DRUG LEVEL FLUCTUATING | 1 0.01 34.49 DRUG LEVEL INCREASED | 6 0.06 34.55 DRUG PRESCRIBING ERROR | 5 0.05 34.60 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 5 0.05 34.65 DRUG SCREEN FALSE POSITIVE | 1 0.01 34.66 DRUG SCREEN POSITIVE | 3 0.03 34.69 DRUG SPECIFIC ANTIBODY PRESENT | 2 0.02 34.71 DRUG WITHDRAWAL SYNDROME | 11 0.11 34.82 DRUG WITHDRAWAL SYNDROME NEONATAL | 2 0.02 34.84 DRY EYE | 4 0.04 34.88 DRY MOUTH | 11 0.11 34.99 DRY SKIN | 8 0.08 35.07 DUODENAL STENOSIS | 1 0.01 35.08 DUODENAL ULCER | 3 0.03 35.11 DUODENAL ULCER HAEMORRHAGE | 4 0.04 35.15 DUODENAL ULCER PERFORATION | 1 0.01 35.16 DYSARTHRIA | 7 0.07 35.23 DYSENTERY | 1 0.01 35.24 DYSGEUSIA | 12 0.12 35.36 DYSKINESIA | 6 0.06 35.42 DYSLALIA | 1 0.01 35.43 DYSLIPIDAEMIA | 1 0.01 35.44 DYSMORPHISM | 1 0.01 35.45 DYSPEPSIA | 11 0.11 35.56 DYSPHAGIA | 16 0.16 35.72 DYSPHONIA | 4 0.04 35.76 DYSPNOEA | 103 1.03 36.79 DYSPNOEA EXERTIONAL | 7 0.07 36.86 DYSSTASIA | 3 0.03 36.89 DYSTONIA | 4 0.04 36.93 DYSURIA | 6 0.06 36.99 EAR CONGESTION | 1 0.01 37.00 EAR DISCOMFORT | 2 0.02 37.02 EAR DISORDER | 1 0.01 37.03 EAR INFECTION | 1 0.01 37.04 EAR PAIN | 3 0.03 37.07 EATING DISORDER | 3 0.03 37.10 EBSTEIN'S ANOMALY | 1 0.01 37.11 ECCHYMOSIS | 1 0.01 37.12 ECTOPIC PREGNANCY | 2 0.02 37.14 ECTOPIC PREGNANCY WITH INTRAUTERINE D.. | 1 0.01 37.15 ECZEMA | 4 0.04 37.19 EFFUSION | 1 0.01 37.20 EJECTION FRACTION DECREASED | 2 0.02 37.22 ELECTROCARDIOGRAM ABNORMAL | 3 0.03 37.25 ELECTROCARDIOGRAM QT PROLONGED | 7 0.07 37.32 ELECTROCARDIOGRAM REPOLARISATION ABNO.. | 1 0.01 37.33 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 2 0.02 37.35 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 1 0.01 37.36 ELECTROCARDIOGRAM T WAVE INVERSION | 1 0.01 37.37 ELECTROENCEPHALOGRAM ABNORMAL | 1 0.01 37.38 ELECTROLYTE IMBALANCE | 3 0.03 37.41 EMBOLIC STROKE | 1 0.01 37.42 EMBOLISM ARTERIAL | 2 0.02 37.44 EMBOLISM VENOUS | 1 0.01 37.45 EMOTIONAL DISORDER | 2 0.02 37.47 EMOTIONAL DISTRESS | 11 0.11 37.58 EMPHYSEMA | 2 0.02 37.60 EMPTY SELLA SYNDROME | 1 0.01 37.61 EMPYEMA | 1 0.01 37.62 ENANTHEMA | 1 0.01 37.63 ENCEPHALOMALACIA | 1 0.01 37.64 ENCEPHALOPATHY | 6 0.06 37.70 ENDOMETRIAL HYPERTROPHY | 1 0.01 37.71 ENDOMETRIOSIS | 2 0.02 37.73 ENDOSCOPIC RETROGRADE CHOLANGIOPANCRE.. | 1 0.01 37.74 ENDOTOXAEMIA | 1 0.01 37.75 ENTERITIS | 1 0.01 37.76 ENTERITIS INFECTIOUS | 1 0.01 37.77 ENTEROBACTER INFECTION | 1 0.01 37.78 ENTEROCOCCAL INFECTION | 2 0.02 37.80 ENTEROCOLITIS | 3 0.03 37.83 ENTEROCOLITIS VIRAL | 1 0.01 37.84 ENURESIS | 1 0.01 37.85 EOSINOPHIL COUNT INCREASED | 1 0.01 37.86 EOSINOPHILIA | 8 0.08 37.94 EOSINOPHILIC FASCIITIS | 1 0.01 37.95 EOSINOPHILIC OESOPHAGITIS | 1 0.01 37.96 EPICONDYLITIS | 3 0.03 37.99 EPIDERMAL NECROSIS | 1 0.01 38.00 EPILEPSY | 2 0.02 38.02 EPISTAXIS | 6 0.06 38.08 EPSTEIN-BARR VIRUS INFECTION | 4 0.04 38.12 EPSTEIN-BARR VIRUS TEST POSITIVE | 1 0.01 38.13 ERECTILE DYSFUNCTION | 7 0.07 38.20 ERECTION INCREASED | 8 0.08 38.28 ERUCTATION | 1 0.01 38.29 ERYSIPELAS | 2 0.02 38.31 ERYTHEMA | 18 0.18 38.49 ERYTHEMA MULTIFORME | 2 0.02 38.51 ERYTHEMA NODOSUM | 1 0.01 38.52 ERYTHROBLAST COUNT DECREASED | 1 0.01 38.53 ERYTHRODERMIC PSORIASIS | 1 0.01 38.54 ESCHERICHIA INFECTION | 3 0.03 38.57 ESCHERICHIA SEPSIS | 1 0.01 38.58 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 38.59 EUPHORIC MOOD | 1 0.01 38.60 EVANS SYNDROME | 1 0.01 38.61 EXCESSIVE GRANULATION TISSUE | 1 0.01 38.62 EXERCISE TOLERANCE DECREASED | 1 0.01 38.63 EXOMPHALOS | 1 0.01 38.64 EXOPHTHALMOS | 2 0.02 38.66 EXPIRED DRUG ADMINISTERED | 4 0.04 38.70 EXPRESSIVE LANGUAGE DISORDER | 2 0.02 38.72 EXTRAPYRAMIDAL DISORDER | 3 0.03 38.75 EXTRASYSTOLES | 1 0.01 38.76 EXTRAVASATION | 2 0.02 38.78 EXTREMITY NECROSIS | 1 0.01 38.79 EYE DISORDER | 8 0.08 38.87 EYE HAEMORRHAGE | 3 0.03 38.90 EYE INFECTION | 2 0.02 38.92 EYE INFECTION STAPHYLOCOCCAL | 1 0.01 38.93 EYE INJURY | 1 0.01 38.94 EYE IRRITATION | 4 0.04 38.98 EYE MOVEMENT DISORDER | 3 0.03 39.01 EYE OEDEMA | 1 0.01 39.02 EYE OPERATION | 1 0.01 39.03 EYE PAIN | 4 0.04 39.07 EYE PRURITUS | 2 0.02 39.09 EYE SWELLING | 5 0.05 39.14 EYELID MARGIN CRUSTING | 1 0.01 39.15 EYELID OEDEMA | 2 0.02 39.17 EYELID PAIN | 1 0.01 39.18 FACE INJURY | 2 0.02 39.20 FACE OEDEMA | 9 0.09 39.29 FACIAL BONES FRACTURE | 2 0.02 39.31 FAECAL INCONTINENCE | 1 0.01 39.32 FAECAL VOMITING | 2 0.02 39.34 FAECES DISCOLOURED | 4 0.04 39.38 FAECES HARD | 1 0.01 39.39 FAECES PALE | 2 0.02 39.41 FALL | 70 0.70 40.11 FALLOPIAN TUBE DISORDER | 1 0.01 40.12 FASCIITIS | 2 0.02 40.14 FATIGUE | 73 0.73 40.87 FEAR | 6 0.06 40.93 FEAR OF DISEASE | 1 0.01 40.94 FEBRILE BONE MARROW APLASIA | 1 0.01 40.95 FEBRILE CONVULSION | 1 0.01 40.96 FEBRILE NEUTROPENIA | 11 0.11 41.07 FEEDING TUBE COMPLICATION | 1 0.01 41.08 FEELING ABNORMAL | 25 0.25 41.33 FEELING COLD | 6 0.06 41.39 FEELING HOT | 6 0.06 41.45 FEELING JITTERY | 7 0.07 41.52 FEELING OF BODY TEMPERATURE CHANGE | 1 0.01 41.53 FEMORAL ARTERIAL STENOSIS | 1 0.01 41.54 FEMORAL NECK FRACTURE | 1 0.01 41.55 FEMUR FRACTURE | 16 0.16 41.71 FIBRIN D DIMER INCREASED | 2 0.02 41.73 FIBROMYALGIA | 2 0.02 41.75 FIBROUS HISTIOCYTOMA | 2 0.02 41.77 FIBULA FRACTURE | 1 0.01 41.78 FISTULA | 2 0.02 41.80 FLANK PAIN | 5 0.05 41.85 FLATULENCE | 9 0.09 41.94 FLOPPY IRIS SYNDROME | 1 0.01 41.95 FLUID OVERLOAD | 3 0.03 41.98 FLUID RETENTION | 3 0.03 42.01 FLUSHING | 10 0.10 42.11 FOETAL DISORDER | 1 0.01 42.12 FOETAL DISTRESS SYNDROME | 1 0.01 42.13 FOLATE DEFICIENCY | 1 0.01 42.14 FOOD ALLERGY | 1 0.01 42.15 FOOT DEFORMITY | 2 0.02 42.17 FOOT FRACTURE | 3 0.03 42.20 FOREIGN BODY | 1 0.01 42.21 FORMICATION | 1 0.01 42.22 FRACTURE | 8 0.08 42.30 FRACTURE DISPLACEMENT | 5 0.05 42.35 FRACTURE TREATMENT | 1 0.01 42.36 FREQUENT BOWEL MOVEMENTS | 1 0.01 42.37 FRONTOTEMPORAL DEMENTIA | 1 0.01 42.38 FULL BLOOD COUNT DECREASED | 1 0.01 42.39 FUNGAEMIA | 1 0.01 42.40 FUNGAL INFECTION | 7 0.07 42.47 FUNGAL SKIN INFECTION | 1 0.01 42.48 GAIT DISTURBANCE | 34 0.34 42.82 GALACTORRHOEA | 4 0.04 42.86 GALLBLADDER CHOLESTEROLOSIS | 1 0.01 42.87 GALLBLADDER DISORDER | 19 0.19 43.06 GALLBLADDER INJURY | 2 0.02 43.08 GALLBLADDER NON-FUNCTIONING | 2 0.02 43.10 GALLBLADDER OPERATION | 3 0.03 43.13 GALLBLADDER PAIN | 2 0.02 43.15 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL | 1 0.01 43.16 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 9 0.09 43.25 GANGRENE | 1 0.01 43.26 GAS POISONING | 1 0.01 43.27 GASTRIC BANDING | 1 0.01 43.28 GASTRIC CANCER | 3 0.03 43.31 GASTRIC DISORDER | 3 0.03 43.34 GASTRIC HAEMORRHAGE | 4 0.04 43.38 GASTRIC PERFORATION | 1 0.01 43.39 GASTRIC STENOSIS | 1 0.01 43.40 GASTRIC ULCER | 2 0.02 43.42 GASTRIC ULCER HAEMORRHAGE | 1 0.01 43.43 GASTRITIS | 6 0.06 43.49 GASTRITIS BACTERIAL | 1 0.01 43.50 GASTRITIS EROSIVE | 3 0.03 43.53 GASTRITIS HAEMORRHAGIC | 1 0.01 43.54 GASTROENTERITIS | 3 0.03 43.57 GASTROENTERITIS VIRAL | 1 0.01 43.58 GASTROINTESTINAL CARCINOMA | 1 0.01 43.59 GASTROINTESTINAL DISORDER | 5 0.05 43.64 GASTROINTESTINAL HAEMORRHAGE | 23 0.23 43.87 GASTROINTESTINAL MOTILITY DISORDER | 2 0.02 43.89 GASTROINTESTINAL MUCOSAL DISORDER | 1 0.01 43.90 GASTROINTESTINAL NECROSIS | 1 0.01 43.91 GASTROINTESTINAL PAIN | 2 0.02 43.93 GASTROINTESTINAL PERFORATION | 1 0.01 43.94 GASTROINTESTINAL STROMAL TUMOUR | 1 0.01 43.95 GASTROINTESTINAL SURGERY | 2 0.02 43.97 GASTROINTESTINAL TOXICITY | 1 0.01 43.98 GASTROINTESTINAL TUBE INSERTION | 1 0.01 43.99 GASTROINTESTINAL ULCER | 1 0.01 44.00 GASTROOESOPHAGEAL REFLUX DISEASE | 5 0.05 44.05 GASTROSCHISIS | 1 0.01 44.06 GENE MUTATION IDENTIFICATION TEST POS.. | 3 0.03 44.09 GENERAL PHYSICAL HEALTH DETERIORATION | 21 0.21 44.30 GENERAL SYMPTOM | 2 0.02 44.32 GENERALISED ERYTHEMA | 4 0.04 44.36 GENERALISED OEDEMA | 6 0.06 44.42 GENITAL HAEMORRHAGE | 2 0.02 44.44 GESTATIONAL DIABETES | 1 0.01 44.45 GINGIVAL BLEEDING | 1 0.01 44.46 GINGIVAL DISORDER | 1 0.01 44.47 GINGIVAL INFECTION | 3 0.03 44.50 GINGIVAL PAIN | 2 0.02 44.52 GINGIVAL SWELLING | 1 0.01 44.53 GINGIVAL ULCERATION | 1 0.01 44.54 GINGIVITIS | 1 0.01 44.55 GLAUCOMA | 3 0.03 44.58 GLIOMA | 1 0.01 44.59 GLOMERULAR FILTRATION RATE DECREASED | 2 0.02 44.61 GLOMERULAR FILTRATION RATE INCREASED | 1 0.01 44.62 GLOMERULONEPHRITIS | 2 0.02 44.64 GLOMERULONEPHRITIS MEMBRANOUS | 1 0.01 44.65 GLOSSODYNIA | 2 0.02 44.67 GLOSSOPTOSIS | 1 0.01 44.68 GLUCOSE TOLERANCE IMPAIRED | 2 0.02 44.70 GLYCOGEN STORAGE DISORDER | 1 0.01 44.71 GLYCOSYLATED HAEMOGLOBIN INCREASED | 3 0.03 44.74 GOITRE | 1 0.01 44.75 GOUT | 3 0.03 44.78 GRAFT VERSUS HOST DISEASE | 8 0.08 44.86 GRAND MAL CONVULSION | 5 0.05 44.91 GRANULOCYTE COUNT DECREASED | 1 0.01 44.92 GRANULOMA | 5 0.05 44.97 GRIP STRENGTH DECREASED | 1 0.01 44.98 GROIN PAIN | 3 0.03 45.01 GUILLAIN-BARRE SYNDROME | 2 0.02 45.03 GYNAECOMASTIA | 1 0.01 45.04 H1N1 INFLUENZA | 2 0.02 45.06 HAEMANGIOMA | 1 0.01 45.07 HAEMATEMESIS | 3 0.03 45.10 HAEMATOCHEZIA | 7 0.07 45.17 HAEMATOCRIT DECREASED | 8 0.08 45.25 HAEMATOMA | 7 0.07 45.32 HAEMATOPOIETIC NEOPLASM | 1 0.01 45.33 HAEMATURIA | 8 0.08 45.41 HAEMODYNAMIC INSTABILITY | 3 0.03 45.44 HAEMOGLOBIN ABNORMAL | 2 0.02 45.46 HAEMOGLOBIN DECREASED | 16 0.16 45.62 HAEMOGLOBIN INCREASED | 2 0.02 45.64 HAEMOLYSIS | 2 0.02 45.66 HAEMOLYTIC ANAEMIA | 8 0.08 45.74 HAEMOPTYSIS | 4 0.04 45.78 HAEMORRHAGE | 12 0.12 45.90 HAEMORRHAGE INTRACRANIAL | 1 0.01 45.91 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 45.92 HAEMORRHAGIC ANAEMIA | 2 0.02 45.94 HAEMORRHAGIC CYST | 1 0.01 45.95 HAEMORRHAGIC DIATHESIS | 1 0.01 45.96 HAEMORRHAGIC OVARIAN CYST | 1 0.01 45.97 HAEMORRHOIDAL HAEMORRHAGE | 2 0.02 45.99 HAEMORRHOIDS | 7 0.07 46.06 HAEMOTHORAX | 1 0.01 46.07 HAIR COLOUR CHANGES | 1 0.01 46.08 HALLUCINATION | 13 0.13 46.21 HALLUCINATION, AUDITORY | 3 0.03 46.24 HALLUCINATION, VISUAL | 3 0.03 46.27 HALLUCINATIONS, MIXED | 1 0.01 46.28 HAND DEFORMITY | 2 0.02 46.30 HANGOVER | 1 0.01 46.31 HAPTOGLOBIN DECREASED | 1 0.01 46.32 HEAD INJURY | 6 0.06 46.38 HEAD TITUBATION | 1 0.01 46.39 HEADACHE | 75 0.75 47.14 HEARING IMPAIRED | 2 0.02 47.16 HEART DISEASE CONGENITAL | 1 0.01 47.17 HEART RATE DECREASED | 9 0.09 47.26 HEART RATE INCREASED | 9 0.09 47.35 HEART RATE IRREGULAR | 8 0.08 47.43 HEAT OEDEMA | 1 0.01 47.44 HELICOBACTER GASTRITIS | 1 0.01 47.45 HELICOBACTER INFECTION | 1 0.01 47.46 HEMIPARESIS | 4 0.04 47.50 HEMIPLEGIA | 5 0.05 47.55 HENOCH-SCHONLEIN PURPURA | 1 0.01 47.56 HEPARIN-INDUCED THROMBOCYTOPENIA | 3 0.03 47.59 HEPATECTOMY | 1 0.01 47.60 HEPATIC ARTERY OCCLUSION | 1 0.01 47.61 HEPATIC ARTERY THROMBOSIS | 1 0.01 47.62 HEPATIC CIRRHOSIS | 5 0.05 47.67 HEPATIC ENCEPHALOPATHY | 1 0.01 47.68 HEPATIC ENZYME INCREASED | 12 0.12 47.80 HEPATIC FAILURE | 10 0.10 47.90 HEPATIC FUNCTION ABNORMAL | 10 0.10 48.00 HEPATIC INFECTION | 1 0.01 48.01 HEPATIC LESION | 1 0.01 48.02 HEPATIC NECROSIS | 3 0.03 48.05 HEPATIC NEOPLASM MALIGNANT | 4 0.04 48.09 HEPATIC PAIN | 1 0.01 48.10 HEPATIC STEATOSIS | 5 0.05 48.15 HEPATITIS | 4 0.04 48.19 HEPATITIS A | 1 0.01 48.20 HEPATITIS ACUTE | 5 0.05 48.25 HEPATITIS B | 2 0.02 48.27 HEPATITIS C | 2 0.02 48.29 HEPATITIS CHOLESTATIC | 2 0.02 48.31 HEPATITIS TOXIC | 1 0.01 48.32 HEPATOBILIARY DISEASE | 1 0.01 48.33 HEPATORENAL SYNDROME | 1 0.01 48.34 HEPATOSPLENIC T-CELL LYMPHOMA | 1 0.01 48.35 HEPATOTOXICITY | 3 0.03 48.38 HERNIA | 2 0.02 48.40 HERNIA REPAIR | 1 0.01 48.41 HERPES OPHTHALMIC | 1 0.01 48.42 HERPES VIRUS INFECTION | 2 0.02 48.44 HERPES ZOSTER | 9 0.09 48.53 HERPES ZOSTER OPHTHALMIC | 2 0.02 48.55 HIATUS HERNIA | 5 0.05 48.60 HICCUPS | 1 0.01 48.61 HIGH DENSITY LIPOPROTEIN DECREASED | 3 0.03 48.64 HIP ARTHROPLASTY | 3 0.03 48.67 HIP FRACTURE | 13 0.13 48.80 HIP SURGERY | 5 0.05 48.85 HIPPOCAMPAL SCLEROSIS | 1 0.01 48.86 HISTIOCYTOSIS HAEMATOPHAGIC | 5 0.05 48.91 HODGKIN'S DISEASE | 2 0.02 48.93 HOMICIDAL IDEATION | 1 0.01 48.94 HORNER'S SYNDROME | 1 0.01 48.95 HOSPICE CARE | 1 0.01 48.96 HOSPITALISATION | 17 0.17 49.13 HOSTILITY | 1 0.01 49.14 HOT FLUSH | 8 0.08 49.22 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE | 2 0.02 49.24 HUMERUS FRACTURE | 3 0.03 49.27 HYDROCEPHALUS | 1 0.01 49.28 HYDRONEPHROSIS | 2 0.02 49.30 HYPERAESTHESIA | 1 0.01 49.31 HYPERAMMONAEMIA | 2 0.02 49.33 HYPERAMYLASAEMIA | 2 0.02 49.35 HYPERBILIRUBINAEMIA | 5 0.05 49.40 HYPERBILIRUBINAEMIA NEONATAL | 2 0.02 49.42 HYPERCALCAEMIA | 4 0.04 49.46 HYPERCAPNIA | 1 0.01 49.47 HYPERCHLORHYDRIA | 1 0.01 49.48 HYPERCHOLESTEROLAEMIA | 2 0.02 49.50 HYPERCREATINAEMIA | 1 0.01 49.51 HYPEREOSINOPHILIC SYNDROME | 1 0.01 49.52 HYPERGLYCAEMIA | 6 0.06 49.58 HYPERHIDROSIS | 18 0.18 49.76 HYPERKALAEMIA | 12 0.12 49.88 HYPERKERATOSIS | 4 0.04 49.92 HYPERLACTACIDAEMIA | 2 0.02 49.94 HYPERLIPIDAEMIA | 1 0.01 49.95 HYPERPROLACTINAEMIA | 2 0.02 49.97 HYPERPROTEINAEMIA | 1 0.01 49.98 HYPERREFLEXIA | 1 0.01 49.99 HYPERSENSITIVITY | 25 0.25 50.24 HYPERSOMNIA | 3 0.03 50.27 HYPERTELORISM OF ORBIT | 1 0.01 50.28 HYPERTENSION | 40 0.40 50.68 HYPERTENSIVE CRISIS | 5 0.05 50.73 HYPERTHERMIA | 6 0.06 50.79 HYPERTONIA | 2 0.02 50.81 HYPERURICAEMIA | 2 0.02 50.83 HYPOACUSIS | 2 0.02 50.85 HYPOAESTHESIA | 28 0.28 51.13 HYPOAESTHESIA FACIAL | 2 0.02 51.15 HYPOAESTHESIA ORAL | 1 0.01 51.16 HYPOALBUMINAEMIA | 4 0.04 51.20 HYPOCALCAEMIA | 7 0.07 51.27 HYPOCHLORAEMIA | 1 0.01 51.28 HYPOCHROMIC ANAEMIA | 1 0.01 51.29 HYPOGLYCAEMIA | 15 0.15 51.44 HYPOGLYCAEMIC COMA | 2 0.02 51.46 HYPOGLYCAEMIC SEIZURE | 2 0.02 51.48 HYPOGLYCAEMIC UNCONSCIOUSNESS | 3 0.03 51.51 HYPOKALAEMIA | 11 0.11 51.62 HYPOKINESIA | 3 0.03 51.65 HYPOMAGNESAEMIA | 3 0.03 51.68 HYPOMANIA | 1 0.01 51.69 HYPONATRAEMIA | 13 0.13 51.82 HYPOPHAGIA | 2 0.02 51.84 HYPOPHOSPHATAEMIA | 1 0.01 51.85 HYPOPLASTIC LEFT HEART SYNDROME | 1 0.01 51.86 HYPOPROTEINAEMIA | 2 0.02 51.88 HYPOSPADIAS | 1 0.01 51.89 HYPOTENSION | 36 0.36 52.25 HYPOTHALAMO-PITUITARY DISORDER | 3 0.03 52.28 HYPOTHERMIA | 1 0.01 52.29 HYPOTHYROIDISM | 5 0.05 52.34 HYPOTONIA | 3 0.03 52.37 HYPOVENTILATION | 2 0.02 52.39 HYPOVOLAEMIA | 2 0.02 52.41 HYPOXIA | 4 0.04 52.45 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY | 1 0.01 52.46 HYSTERECTOMY | 4 0.04 52.50 IDEAS OF REFERENCE | 1 0.01 52.51 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 3 0.03 52.54 ILEAL PERFORATION | 1 0.01 52.55 ILEAL ULCER | 1 0.01 52.56 ILEUS | 6 0.06 52.62 ILEUS PARALYTIC | 7 0.07 52.69 ILIAC VEIN OCCLUSION | 1 0.01 52.70 ILL-DEFINED DISORDER | 9 0.09 52.79 ILLUSION | 1 0.01 52.80 IMMUNE RECONSTITUTION SYNDROME | 3 0.03 52.83 IMMUNODEFICIENCY | 1 0.01 52.84 IMPAIRED DRIVING ABILITY | 3 0.03 52.87 IMPAIRED GASTRIC EMPTYING | 3 0.03 52.90 IMPAIRED HEALING | 2 0.02 52.92 IMPAIRED WORK ABILITY | 1 0.01 52.93 IMPETIGO | 2 0.02 52.95 INADEQUATE ANALGESIA | 2 0.02 52.97 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 3 0.03 53.00 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 8 0.08 53.08 INCISION SITE INFECTION | 1 0.01 53.09 INCOHERENT | 1 0.01 53.10 INCONTINENCE | 3 0.03 53.13 INCORRECT DOSE ADMINISTERED | 11 0.11 53.24 INCORRECT DRUG ADMINISTRATION DURATION | 5 0.05 53.29 INCORRECT ROUTE OF DRUG ADMINISTRATION | 8 0.08 53.37 INCORRECT STORAGE OF DRUG | 1 0.01 53.38 INCREASED APPETITE | 1 0.01 53.39 INCREASED BRONCHIAL SECRETION | 1 0.01 53.40 INCREASED TENDENCY TO BRUISE | 2 0.02 53.42 INCREASED UPPER AIRWAY SECRETION | 3 0.03 53.45 INFARCTION | 1 0.01 53.46 INFECTED LYMPHOCELE | 1 0.01 53.47 INFECTED SKIN ULCER | 1 0.01 53.48 INFECTION | 18 0.18 53.66 INFECTIOUS DISEASE CARRIER | 1 0.01 53.67 INFECTIOUS MONONUCLEOSIS | 1 0.01 53.68 INFERIOR VENA CAVAL OCCLUSION | 1 0.01 53.69 INFERTILITY | 1 0.01 53.70 INFLAMMATION | 3 0.03 53.73 INFLAMMATORY BOWEL DISEASE | 1 0.01 53.74 INFLAMMATORY PAIN | 1 0.01 53.75 INFLUENZA | 4 0.04 53.79 INFLUENZA LIKE ILLNESS | 17 0.17 53.96 INFUSION RELATED REACTION | 7 0.07 54.03 INFUSION SITE ABSCESS | 1 0.01 54.04 INFUSION SITE EXTRAVASATION | 2 0.02 54.06 INFUSION SITE INFECTION | 1 0.01 54.07 INGUINAL HERNIA | 1 0.01 54.08 INJECTION SITE ABSCESS | 1 0.01 54.09 INJECTION SITE ATROPHY | 1 0.01 54.10 INJECTION SITE DISCHARGE | 1 0.01 54.11 INJECTION SITE DISCOLOURATION | 2 0.02 54.13 INJECTION SITE DISCOMFORT | 1 0.01 54.14 INJECTION SITE ERYTHEMA | 5 0.05 54.19 INJECTION SITE HAEMATOMA | 4 0.04 54.23 INJECTION SITE HAEMORRHAGE | 1 0.01 54.24 INJECTION SITE HYPERSENSITIVITY | 1 0.01 54.25 INJECTION SITE INDURATION | 3 0.03 54.28 INJECTION SITE INFLAMMATION | 1 0.01 54.29 INJECTION SITE INJURY | 1 0.01 54.30 INJECTION SITE MASS | 2 0.02 54.32 INJECTION SITE NECROSIS | 1 0.01 54.33 INJECTION SITE NODULE | 1 0.01 54.34 INJECTION SITE PAIN | 11 0.11 54.45 INJECTION SITE PRURITUS | 2 0.02 54.47 INJECTION SITE REACTION | 5 0.05 54.52 INJECTION SITE SWELLING | 3 0.03 54.55 INJECTION SITE URTICARIA | 1 0.01 54.56 INJURY | 63 0.63 55.19 INJURY ASSOCIATED WITH DEVICE | 2 0.02 55.21 INSOMNIA | 32 0.32 55.53 INSULIN-LIKE GROWTH FACTOR INCREASED | 1 0.01 55.54 INTENTION TREMOR | 1 0.01 55.55 INTENTIONAL DRUG MISUSE | 7 0.07 55.62 INTENTIONAL OVERDOSE | 12 0.12 55.74 INTERMITTENT CLAUDICATION | 1 0.01 55.75 INTERNAL FIXATION OF FRACTURE | 1 0.01 55.76 INTERNATIONAL NORMALISED RATIO ABNORMAL | 1 0.01 55.77 INTERNATIONAL NORMALISED RATIO INCREA.. | 10 0.10 55.87 INTERSTITIAL LUNG DISEASE | 13 0.13 56.00 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 56.01 INTERVERTEBRAL DISC DISORDER | 2 0.02 56.03 INTERVERTEBRAL DISC OPERATION | 3 0.03 56.06 INTERVERTEBRAL DISC PROTRUSION | 3 0.03 56.09 INTESTINAL CONGESTION | 1 0.01 56.10 INTESTINAL ISCHAEMIA | 1 0.01 56.11 INTESTINAL MASS | 1 0.01 56.12 INTESTINAL OBSTRUCTION | 2 0.02 56.14 INTESTINAL PERFORATION | 6 0.06 56.20 INTESTINAL RESECTION | 2 0.02 56.22 INTRA-UTERINE DEATH | 6 0.06 56.28 INTRACARDIAC THROMBUS | 3 0.03 56.31 INTRACRANIAL ANEURYSM | 1 0.01 56.32 INTRACRANIAL HAEMATOMA | 1 0.01 56.33 INTRACRANIAL HYPOTENSION | 2 0.02 56.35 INTRACRANIAL PRESSURE INCREASED | 1 0.01 56.36 INTRACRANIAL TUMOUR HAEMORRHAGE | 1 0.01 56.37 INTRAMEDULLARY ROD INSERTION | 2 0.02 56.39 INTRAOCULAR PRESSURE INCREASED | 2 0.02 56.41 INTRAVENTRICULAR HAEMORRHAGE | 1 0.01 56.42 IRIS DISORDER | 1 0.01 56.43 IRON BINDING CAPACITY TOTAL DECREASED | 1 0.01 56.44 IRON DEFICIENCY | 2 0.02 56.46 IRON OVERLOAD | 1 0.01 56.47 IRRITABILITY | 3 0.03 56.50 IRRITABLE BOWEL SYNDROME | 1 0.01 56.51 ISCHAEMIA | 1 0.01 56.52 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 56.53 ISCHAEMIC CEREBRAL INFARCTION | 1 0.01 56.54 ISCHAEMIC STROKE | 2 0.02 56.56 JAUNDICE | 12 0.12 56.68 JAUNDICE CHOLESTATIC | 1 0.01 56.69 JAW DISORDER | 3 0.03 56.72 JC VIRUS TEST POSITIVE | 1 0.01 56.73 JOINT ANKYLOSIS | 1 0.01 56.74 JOINT ARTHROPLASTY | 1 0.01 56.75 JOINT DISLOCATION | 4 0.04 56.79 JOINT INJURY | 4 0.04 56.83 JOINT RANGE OF MOTION DECREASED | 4 0.04 56.87 JOINT STIFFNESS | 6 0.06 56.93 JOINT SWELLING | 13 0.13 57.06 JUGULAR VEIN THROMBOSIS | 1 0.01 57.07 KERATORHEXIS | 1 0.01 57.08 KETONURIA | 1 0.01 57.09 KETOSIS | 1 0.01 57.10 KIDNEY INFECTION | 5 0.05 57.15 KIDNEY TRANSPLANT REJECTION | 1 0.01 57.16 KLEBSIELLA BACTERAEMIA | 1 0.01 57.17 KLEBSIELLA INFECTION | 1 0.01 57.18 KLEBSIELLA SEPSIS | 1 0.01 57.19 KNEE ARTHROPLASTY | 1 0.01 57.20 KNEE DEFORMITY | 1 0.01 57.21 KNEE OPERATION | 2 0.02 57.23 LABILE BLOOD PRESSURE | 1 0.01 57.24 LABORATORY TEST ABNORMAL | 1 0.01 57.25 LABYRINTHITIS | 2 0.02 57.27 LACERATION | 4 0.04 57.31 LACK OF SPONTANEOUS SPEECH | 1 0.01 57.32 LACRIMATION INCREASED | 2 0.02 57.34 LACTIC ACIDOSIS | 4 0.04 57.38 LACUNAR INFARCTION | 2 0.02 57.40 LARGE INTESTINAL HAEMORRHAGE | 1 0.01 57.41 LARGE INTESTINAL ULCER HAEMORRHAGE | 1 0.01 57.42 LARGE INTESTINE CARCINOMA | 3 0.03 57.45 LARGE INTESTINE PERFORATION | 2 0.02 57.47 LARYNGEAL CANCER | 1 0.01 57.48 LARYNGEAL DISORDER | 1 0.01 57.49 LARYNGEAL OEDEMA | 2 0.02 57.51 LARYNGOSPASM | 2 0.02 57.53 LATENT TUBERCULOSIS | 1 0.01 57.54 LEFT VENTRICULAR DYSFUNCTION | 1 0.01 57.55 LEFT VENTRICULAR FAILURE | 3 0.03 57.58 LEFT VENTRICULAR HYPERTROPHY | 1 0.01 57.59 LEG AMPUTATION | 1 0.01 57.60 LENTIGO MALIGNA STAGE II | 1 0.01 57.61 LESION EXCISION | 1 0.01 57.62 LETHARGY | 4 0.04 57.66 LEUKAEMIA | 1 0.01 57.67 LEUKAEMIC INFILTRATION BRAIN | 1 0.01 57.68 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 57.69 LEUKOCYTOSIS | 4 0.04 57.73 LEUKOENCEPHALOPATHY | 1 0.01 57.74 LEUKOPENIA | 11 0.11 57.85 LIBIDO DECREASED | 1 0.01 57.86 LIBIDO DISORDER | 1 0.01 57.87 LICHENOID KERATOSIS | 1 0.01 57.88 LIFE EXPECTANCY SHORTENED | 1 0.01 57.89 LIFE SUPPORT | 1 0.01 57.90 LIGAMENT INJURY | 2 0.02 57.92 LIGAMENT RUPTURE | 3 0.03 57.95 LIMB DEFORMITY | 1 0.01 57.96 LIMB DISCOMFORT | 2 0.02 57.98 LIMB OPERATION | 1 0.01 57.99 LIP DRY | 2 0.02 58.01 LIP HAEMORRHAGE | 1 0.01 58.02 LIP INJURY | 1 0.01 58.03 LIP NEOPLASM MALIGNANT STAGE UNSPECIF.. | 1 0.01 58.04 LIP OEDEMA | 2 0.02 58.06 LIP SWELLING | 3 0.03 58.09 LIPASE INCREASED | 1 0.01 58.10 LIVE BIRTH | 1 0.01 58.11 LIVER ABSCESS | 2 0.02 58.13 LIVER DISORDER | 18 0.18 58.31 LIVER FUNCTION TEST ABNORMAL | 13 0.13 58.44 LIVER INJURY | 4 0.04 58.48 LIVER OPERATION | 1 0.01 58.49 LIVER TRANSPLANT | 1 0.01 58.50 LIVIDITY | 1 0.01 58.51 LOCAL SWELLING | 3 0.03 58.54 LOCALISED INFECTION | 2 0.02 58.56 LOCALISED OEDEMA | 1 0.01 58.57 LONG QT SYNDROME | 1 0.01 58.58 LOSS OF CONSCIOUSNESS | 38 0.38 58.96 LOSS OF LIBIDO | 1 0.01 58.97 LOW DENSITY LIPOPROTEIN DECREASED | 1 0.01 58.98 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 58.99 LOWER LIMB FRACTURE | 3 0.03 59.02 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 59.04 LUMBAR VERTEBRAL FRACTURE | 1 0.01 59.05 LUNG ABSCESS | 2 0.02 59.07 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 59.08 LUNG CONSOLIDATION | 1 0.01 59.09 LUNG DISORDER | 9 0.09 59.18 LUNG INFECTION | 5 0.05 59.23 LUNG INFILTRATION | 8 0.08 59.31 LUNG LOBECTOMY | 1 0.01 59.32 LUNG NEOPLASM | 2 0.02 59.34 LUNG NEOPLASM MALIGNANT | 8 0.08 59.42 LUNG OPERATION | 1 0.01 59.43 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 2 0.02 59.45 LUNG TRANSPLANT | 2 0.02 59.47 LYMPH NODE PAIN | 2 0.02 59.49 LYMPH NODE TUBERCULOSIS | 2 0.02 59.51 LYMPHADENECTOMY | 3 0.03 59.54 LYMPHADENITIS | 2 0.02 59.56 LYMPHADENOPATHY | 14 0.14 59.70 LYMPHADENOPATHY MEDIASTINAL | 1 0.01 59.71 LYMPHOCYTE COUNT DECREASED | 2 0.02 59.73 LYMPHOCYTE COUNT INCREASED | 1 0.01 59.74 LYMPHOCYTE MORPHOLOGY ABNORMAL | 1 0.01 59.75 LYMPHOCYTE STIMULATION TEST POSITIVE | 1 0.01 59.76 LYMPHOCYTIC INFILTRATION | 2 0.02 59.78 LYMPHOCYTOSIS | 1 0.01 59.79 LYMPHOMA | 4 0.04 59.83 LYMPHOPENIA | 1 0.01 59.84 LYMPHOPROLIFERATIVE DISORDER | 2 0.02 59.86 MACROGLOSSIA | 1 0.01 59.87 MACULAR DEGENERATION | 1 0.01 59.88 MACULAR HOLE | 1 0.01 59.89 MAJOR DEPRESSION | 1 0.01 59.90 MALAISE | 59 0.59 60.49 MALIGNANT MELANOMA | 1 0.01 60.50 MALIGNANT MELANOMA STAGE III | 1 0.01 60.51 MALIGNANT PLEURAL EFFUSION | 1 0.01 60.52 MALLORY-WEISS SYNDROME | 1 0.01 60.53 MALNUTRITION | 5 0.05 60.58 MANIA | 1 0.01 60.59 MANTLE CELL LYMPHOMA | 1 0.01 60.60 MASS | 2 0.02 60.62 MASTICATION DISORDER | 2 0.02 60.64 MATERNAL CONDITION AFFECTING FOETUS | 1 0.01 60.65 MATERNAL DRUGS AFFECTING FOETUS | 7 0.07 60.72 MEAN CELL HAEMOGLOBIN CONCENTRATION D.. | 1 0.01 60.73 MEAN CELL VOLUME DECREASED | 1 0.01 60.74 MEAN CELL VOLUME INCREASED | 1 0.01 60.75 MECHANICAL ILEUS | 1 0.01 60.76 MEDICAL DEVICE REMOVAL | 1 0.01 60.77 MEDICATION ERROR | 1 0.01 60.78 MEDICATION RESIDUE | 1 0.01 60.79 MELAENA | 2 0.02 60.81 MELANOCYTIC NAEVUS | 1 0.01 60.82 MEMORY IMPAIRMENT | 18 0.18 61.00 MENINGEAL DISORDER | 1 0.01 61.01 MENINGITIS | 2 0.02 61.03 MENINGITIS ASEPTIC | 1 0.01 61.04 MENINGITIS BACTERIAL | 1 0.01 61.05 MENINGITIS LISTERIA | 1 0.01 61.06 MENINGOCOCCAL SEPSIS | 1 0.01 61.07 MENISCUS LESION | 6 0.06 61.13 MENOPAUSE | 1 0.01 61.14 MENORRHAGIA | 4 0.04 61.18 MENSTRUAL DISORDER | 1 0.01 61.19 MENSTRUATION DELAYED | 1 0.01 61.20 MENSTRUATION IRREGULAR | 2 0.02 61.22 MENTAL DISABILITY | 1 0.01 61.23 MENTAL DISORDER | 9 0.09 61.32 MENTAL IMPAIRMENT | 2 0.02 61.34 MENTAL STATUS CHANGES | 8 0.08 61.42 MESENTERIC VEIN THROMBOSIS | 1 0.01 61.43 METABOLIC ACIDOSIS | 9 0.09 61.52 METABOLIC ALKALOSIS | 1 0.01 61.53 METABOLIC DISORDER | 1 0.01 61.54 METABOLIC FUNCTION TEST ABNORMAL | 1 0.01 61.55 METABOLIC SYNDROME | 1 0.01 61.56 METASTASES TO BONE | 4 0.04 61.60 METASTASES TO LIVER | 5 0.05 61.65 METASTASES TO LUNG | 1 0.01 61.66 METASTASES TO LYMPH NODES | 1 0.01 61.67 METASTASES TO PERITONEUM | 1 0.01 61.68 METASTASES TO SPINE | 2 0.02 61.70 METASTASIS | 2 0.02 61.72 METASTATIC RENAL CELL CARCINOMA | 3 0.03 61.75 METRORRHAGIA | 3 0.03 61.78 MICROANGIOPATHY | 1 0.01 61.79 MICROCEPHALY | 3 0.03 61.82 MICROGNATHIA | 1 0.01 61.83 MICTURITION FREQUENCY DECREASED | 1 0.01 61.84 MICTURITION URGENCY | 1 0.01 61.85 MIDDLE INSOMNIA | 1 0.01 61.86 MIGRAINE | 4 0.04 61.90 MIGRAINE WITH AURA | 1 0.01 61.91 MIOSIS | 1 0.01 61.92 MITRAL VALVE DISEASE | 1 0.01 61.93 MITRAL VALVE INCOMPETENCE | 4 0.04 61.97 MOBILITY DECREASED | 12 0.12 62.09 MOLLUSCUM CONTAGIOSUM | 1 0.01 62.10 MONOCLONAL GAMMOPATHY | 1 0.01 62.11 MONOCYTE COUNT INCREASED | 1 0.01 62.12 MONOCYTOPENIA | 1 0.01 62.13 MONOPARESIS | 3 0.03 62.16 MONOPLEGIA | 1 0.01 62.17 MOOD ALTERED | 1 0.01 62.18 MOOD SWINGS | 2 0.02 62.20 MOTION SICKNESS | 1 0.01 62.21 MOTOR DYSFUNCTION | 1 0.01 62.22 MOTOR NEURONE DISEASE | 1 0.01 62.23 MOUTH ULCERATION | 4 0.04 62.27 MOVEMENT DISORDER | 4 0.04 62.31 MUCOSAL INFLAMMATION | 9 0.09 62.40 MUCOSAL NECROSIS | 1 0.01 62.41 MULTI-ORGAN FAILURE | 11 0.11 62.52 MULTIPLE CONGENITAL ABNORMALITIES | 5 0.05 62.57 MULTIPLE DRUG OVERDOSE | 3 0.03 62.60 MULTIPLE DRUG OVERDOSE INTENTIONAL | 2 0.02 62.62 MULTIPLE FRACTURES | 2 0.02 62.64 MULTIPLE MYELOMA | 7 0.07 62.71 MULTIPLE SCLEROSIS | 13 0.13 62.84 MULTIPLE SCLEROSIS RELAPSE | 24 0.24 63.08 MUSCLE ABSCESS | 1 0.01 63.09 MUSCLE ATROPHY | 5 0.05 63.14 MUSCLE DISORDER | 4 0.04 63.18 MUSCLE HAEMORRHAGE | 3 0.03 63.21 MUSCLE RIGIDITY | 2 0.02 63.23 MUSCLE RUPTURE | 2 0.02 63.25 MUSCLE SPASMS | 29 0.29 63.54 MUSCLE SPASTICITY | 1 0.01 63.55 MUSCLE STRAIN | 1 0.01 63.56 MUSCLE TIGHTNESS | 2 0.02 63.58 MUSCLE TWITCHING | 4 0.04 63.62 MUSCULAR WEAKNESS | 25 0.25 63.87 MUSCULOSKELETAL CHEST PAIN | 1 0.01 63.88 MUSCULOSKELETAL DISCOMFORT | 2 0.02 63.90 MUSCULOSKELETAL DISORDER | 2 0.02 63.92 MUSCULOSKELETAL PAIN | 18 0.18 64.10 MUSCULOSKELETAL STIFFNESS | 15 0.15 64.25 MYALGIA | 38 0.38 64.63 MYASTHENIA GRAVIS | 1 0.01 64.64 MYASTHENIA GRAVIS CRISIS | 1 0.01 64.65 MYCOBACTERIAL INFECTION | 1 0.01 64.66 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 2 0.02 64.68 MYCOBACTERIUM TUBERCULOSIS COMPLEX TE.. | 1 0.01 64.69 MYCOSIS FUNGOIDES | 1 0.01 64.70 MYDRIASIS | 1 0.01 64.71 MYELITIS | 1 0.01 64.72 MYELODYSPLASTIC SYNDROME | 11 0.11 64.83 MYELODYSPLASTIC SYNDROME TRANSFORMATION | 1 0.01 64.84 MYELOFIBROSIS | 2 0.02 64.86 MYELOMA RECURRENCE | 1 0.01 64.87 MYOCARDIAL DEPRESSION | 1 0.01 64.88 MYOCARDIAL INFARCTION | 100 1.00 65.88 MYOCARDIAL ISCHAEMIA | 5 0.05 65.93 MYOCARDITIS | 2 0.02 65.95 MYOCLONUS | 4 0.04 65.99 MYOGLOBIN BLOOD INCREASED | 1 0.01 66.00 MYOPATHY | 1 0.01 66.01 MYOPERICARDITIS | 1 0.01 66.02 MYOSITIS | 5 0.05 66.07 NAIL HYPERTROPHY | 1 0.01 66.08 NARROW ANTERIOR CHAMBER ANGLE | 1 0.01 66.09 NASAL CONGESTION | 11 0.11 66.20 NASAL DRYNESS | 2 0.02 66.22 NASOPHARYNGITIS | 19 0.19 66.41 NAUSEA | 117 1.17 67.58 NECK MASS | 1 0.01 67.59 NECK PAIN | 12 0.12 67.71 NECROSIS | 4 0.04 67.75 NEGATIVE THOUGHTS | 3 0.03 67.78 NEONATAL INFECTION | 1 0.01 67.79 NEOPLASM | 3 0.03 67.82 NEOPLASM MALIGNANT | 38 0.38 68.20 NEPHRECTOMY | 1 0.01 68.21 NEPHRITIS | 1 0.01 68.22 NEPHROGENIC DIABETES INSIPIDUS | 1 0.01 68.23 NEPHROLITHIASIS | 9 0.09 68.32 NEPHROPATHY | 4 0.04 68.36 NEPHROPATHY TOXIC | 4 0.04 68.40 NEPHROTIC SYNDROME | 6 0.06 68.46 NERVE COMPRESSION | 1 0.01 68.47 NERVE INJURY | 1 0.01 68.48 NERVOUS SYSTEM DISORDER | 7 0.07 68.55 NERVOUSNESS | 13 0.13 68.68 NEURALGIA | 6 0.06 68.74 NEURITIS | 2 0.02 68.76 NEURODEGENERATIVE DISORDER | 1 0.01 68.77 NEUROENDOCRINE CARCINOMA | 1 0.01 68.78 NEUROLEPTIC MALIGNANT SYNDROME | 1 0.01 68.79 NEUROLOGICAL DECOMPENSATION | 1 0.01 68.80 NEUROLOGICAL SYMPTOM | 2 0.02 68.82 NEUROPATHY PERIPHERAL | 8 0.08 68.90 NEUROTOXICITY | 2 0.02 68.92 NEUTROPENIA | 26 0.26 69.18 NEUTROPENIC SEPSIS | 1 0.01 69.19 NEUTROPHIL COUNT DECREASED | 8 0.08 69.27 NEUTROPHIL COUNT INCREASED | 2 0.02 69.29 NIGHT BLINDNESS | 2 0.02 69.31 NIGHT SWEATS | 2 0.02 69.33 NIGHTMARE | 3 0.03 69.36 NO ADVERSE EVENT | 8 0.08 69.44 NO THERAPEUTIC RESPONSE | 1 0.01 69.45 NODULE | 3 0.03 69.48 NON-CARDIAC CHEST PAIN | 2 0.02 69.50 NON-HODGKIN'S LYMPHOMA | 2 0.02 69.52 NORMAL TENSION GLAUCOMA | 1 0.01 69.53 NUCHAL RIGIDITY | 1 0.01 69.54 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 69.55 NUTRITIONAL CONDITION ABNORMAL | 1 0.01 69.56 NYSTAGMUS | 1 0.01 69.57 OBESITY | 3 0.03 69.60 OBESITY SURGERY | 2 0.02 69.62 OBLITERATIVE BRONCHIOLITIS | 1 0.01 69.63 OBSESSIVE-COMPULSIVE DISORDER | 3 0.03 69.66 OBSTRUCTIVE AIRWAYS DISORDER | 2 0.02 69.68 OCULAR FISTULA | 1 0.01 69.69 OCULAR HYPERAEMIA | 4 0.04 69.73 OCULAR HYPERTENSION | 1 0.01 69.74 OCULAR ICTERUS | 2 0.02 69.76 OCULOGYRIC CRISIS | 1 0.01 69.77 OCULOMUCOCUTANEOUS SYNDROME | 2 0.02 69.79 OEDEMA | 17 0.17 69.96 OEDEMA GENITAL | 1 0.01 69.97 OEDEMA MOUTH | 2 0.02 69.99 OEDEMA PERIPHERAL | 46 0.46 70.45 OEDEMATOUS PANCREATITIS | 1 0.01 70.46 OESOPHAGEAL ADENOCARCINOMA | 1 0.01 70.47 OESOPHAGEAL CANDIDIASIS | 1 0.01 70.48 OESOPHAGEAL DISCOMFORT | 1 0.01 70.49 OESOPHAGEAL DISORDER | 1 0.01 70.50 OESOPHAGEAL PAIN | 3 0.03 70.53 OESOPHAGEAL PERFORATION | 1 0.01 70.54 OESOPHAGEAL POLYP | 1 0.01 70.55 OESOPHAGEAL ULCER | 4 0.04 70.59 OESOPHAGITIS | 4 0.04 70.63 OFF LABEL USE | 9 0.09 70.72 OLIGODIPSIA | 1 0.01 70.73 OLIGOMENORRHOEA | 1 0.01 70.74 OLIGURIA | 3 0.03 70.77 ONYCHOMADESIS | 1 0.01 70.78 OOPHORECTOMY | 2 0.02 70.80 OPEN REDUCTION OF FRACTURE | 1 0.01 70.81 OPPORTUNISTIC INFECTION | 2 0.02 70.83 OPTIC NERVE DISORDER | 1 0.01 70.84 OPTIC NEURITIS | 1 0.01 70.85 OPTIC NEUROPATHY | 1 0.01 70.86 ORAL CANDIDIASIS | 1 0.01 70.87 ORAL DISORDER | 1 0.01 70.88 ORAL DYSAESTHESIA | 1 0.01 70.89 ORAL HERPES | 1 0.01 70.90 ORAL INFECTION | 1 0.01 70.91 ORAL PAIN | 2 0.02 70.93 ORGANISING PNEUMONIA | 1 0.01 70.94 OROPHARYNGEAL DISCOMFORT | 3 0.03 70.97 OROPHARYNGEAL PAIN | 18 0.18 71.15 OROPHARYNGEAL SWELLING | 1 0.01 71.16 ORTHOSTATIC HYPOTENSION | 4 0.04 71.20 OSTEITIS | 3 0.03 71.23 OSTEOARTHRITIS | 9 0.09 71.32 OSTEOLYSIS | 1 0.01 71.33 OSTEOMYELITIS | 7 0.07 71.40 OSTEONECROSIS | 5 0.05 71.45 OSTEONECROSIS OF JAW | 18 0.18 71.63 OSTEOPENIA | 8 0.08 71.71 OSTEOPOROSIS | 8 0.08 71.79 OSTEOPOROTIC FRACTURE | 1 0.01 71.80 OTITIS MEDIA | 2 0.02 71.82 OVARIAN CANCER | 1 0.01 71.83 OVARIAN CANCER METASTATIC | 1 0.01 71.84 OVARIAN CYST | 8 0.08 71.92 OVARIAN CYST RUPTURED | 1 0.01 71.93 OVARIAN DISORDER | 1 0.01 71.94 OVARIAN MASS | 1 0.01 71.95 OVARIAN NEOPLASM | 1 0.01 71.96 OVERDOSE | 57 0.57 72.53 OVERGROWTH BACTERIAL | 1 0.01 72.54 OXYGEN SATURATION ABNORMAL | 1 0.01 72.55 OXYGEN SATURATION DECREASED | 7 0.07 72.62 PAIN | 147 1.47 74.09 PAIN IN EXTREMITY | 61 0.61 74.70 PAIN IN JAW | 6 0.06 74.76 PAINFUL RESPIRATION | 1 0.01 74.77 PALLOR | 7 0.07 74.84 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 9 0.09 74.93 PALPITATIONS | 10 0.10 75.03 PANCREATIC CARCINOMA | 3 0.03 75.06 PANCREATIC CYST | 1 0.01 75.07 PANCREATIC DISORDER | 1 0.01 75.08 PANCREATIC DUCT DILATATION | 1 0.01 75.09 PANCREATIC MASS | 1 0.01 75.10 PANCREATIC NEOPLASM | 1 0.01 75.11 PANCREATITIS | 9 0.09 75.20 PANCREATITIS ACUTE | 7 0.07 75.27 PANCREATITIS CHRONIC | 1 0.01 75.28 PANCREATITIS RELAPSING | 1 0.01 75.29 PANCYTOPENIA | 14 0.14 75.43 PANIC ATTACK | 6 0.06 75.49 PANIC DISORDER | 2 0.02 75.51 PANIC REACTION | 3 0.03 75.54 PANNICULITIS | 1 0.01 75.55 PAPILLOEDEMA | 2 0.02 75.57 PAPULE | 2 0.02 75.59 PARADOXICAL DRUG REACTION | 1 0.01 75.60 PARAESTHESIA | 28 0.28 75.88 PARAESTHESIA ORAL | 1 0.01 75.89 PARAKERATOSIS | 1 0.01 75.90 PARALYSIS | 4 0.04 75.94 PARANASAL SINUS HYPERSECRETION | 1 0.01 75.95 PARANEOPLASTIC CEREBELLAR DEGENERATION | 1 0.01 75.96 PARANOIA | 3 0.03 75.99 PARAPARESIS | 2 0.02 76.01 PARAPLEGIA | 1 0.01 76.02 PARATHYROIDECTOMY | 1 0.01 76.03 PARESIS | 1 0.01 76.04 PARKINSON'S DISEASE | 4 0.04 76.08 PARKINSONISM | 3 0.03 76.11 PAROPHTHALMIA | 1 0.01 76.12 PAROSMIA | 2 0.02 76.14 PARTIAL SEIZURES | 2 0.02 76.16 PATENT DUCTUS ARTERIOSUS | 7 0.07 76.23 PATHOLOGICAL FRACTURE | 2 0.02 76.25 PELVIC FRACTURE | 6 0.06 76.31 PELVIC INFLAMMATORY DISEASE | 1 0.01 76.32 PELVIC PAIN | 5 0.05 76.37 PEMPHIGOID | 2 0.02 76.39 PENILE PROSTHESIS INSERTION | 1 0.01 76.40 PENILE ULCERATION | 1 0.01 76.41 PENIS DISORDER | 1 0.01 76.42 PEPTIC ULCER | 1 0.01 76.43 PERFORMANCE STATUS DECREASED | 2 0.02 76.45 PERIARTHRITIS | 1 0.01 76.46 PERICARDIAL EFFUSION | 11 0.11 76.57 PERICARDIAL EXCISION | 1 0.01 76.58 PERICARDITIS | 1 0.01 76.59 PERIORBITAL OEDEMA | 1 0.01 76.60 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 3 0.03 76.63 PERIPHERAL COLDNESS | 2 0.02 76.65 PERIPHERAL EMBOLISM | 2 0.02 76.67 PERIPHERAL ISCHAEMIA | 2 0.02 76.69 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 76.70 PERIPHERAL SENSORIMOTOR NEUROPATHY | 1 0.01 76.71 PERIPHERAL SENSORY NEUROPATHY | 2 0.02 76.73 PERITONEAL DISORDER | 1 0.01 76.74 PERITONEAL EFFLUENT ABNORMAL | 1 0.01 76.75 PERITONEAL MESOTHELIOMA MALIGNANT | 1 0.01 76.76 PERITONITIS | 11 0.11 76.87 PERITONITIS BACTERIAL | 1 0.01 76.88 PERONEAL NERVE PALSY | 1 0.01 76.89 PERSECUTORY DELUSION | 1 0.01 76.90 PERSONALITY CHANGE | 1 0.01 76.91 PERTUSSIS | 1 0.01 76.92 PETECHIAE | 1 0.01 76.93 PETIT MAL EPILEPSY | 2 0.02 76.95 PHARYNGEAL MASS | 1 0.01 76.96 PHARYNGEAL OEDEMA | 2 0.02 76.98 PHARYNGITIS | 1 0.01 76.99 PHLEBITIS | 3 0.03 77.02 PHOBIA | 1 0.01 77.03 PHOTOPSIA | 2 0.02 77.05 PHOTOSENSITIVITY REACTION | 4 0.04 77.09 PHYSICAL DISABILITY | 1 0.01 77.10 PICA | 1 0.01 77.11 PIERRE ROBIN SYNDROME | 1 0.01 77.12 PIGMENTATION DISORDER | 1 0.01 77.13 PINEAL NEOPLASM | 1 0.01 77.14 PITUITARY TUMOUR | 1 0.01 77.15 PITUITARY TUMOUR RECURRENT | 1 0.01 77.16 PITUITARY TUMOUR REMOVAL | 1 0.01 77.17 PLANTAR ERYTHEMA | 1 0.01 77.18 PLANTAR FASCIITIS | 3 0.03 77.21 PLASMABLASTIC LYMPHOMA | 2 0.02 77.23 PLASMAPHERESIS | 1 0.01 77.24 PLATELET COUNT DECREASED | 19 0.19 77.43 PLATELET COUNT INCREASED | 2 0.02 77.45 PLEURAL EFFUSION | 12 0.12 77.57 PLEURAL INFECTION | 1 0.01 77.58 PLEURISY | 1 0.01 77.59 PNEUMOCYSTIS JIROVECI PNEUMONIA | 5 0.05 77.64 PNEUMONIA | 81 0.81 78.45 PNEUMONIA ASPIRATION | 6 0.06 78.51 PNEUMONIA FUNGAL | 2 0.02 78.53 PNEUMONIA KLEBSIELLA | 1 0.01 78.54 PNEUMONIA LEGIONELLA | 1 0.01 78.55 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 78.56 PNEUMONITIS | 5 0.05 78.61 PNEUMOPERITONEUM | 1 0.01 78.62 PNEUMOTHORAX | 6 0.06 78.68 POLLAKIURIA | 6 0.06 78.74 POLYARTHRITIS | 3 0.03 78.77 POLYCYSTIC LIVER DISEASE | 1 0.01 78.78 POLYCYTHAEMIA | 2 0.02 78.80 POLYDACTYLY | 1 0.01 78.81 POLYHYDRAMNIOS | 1 0.01 78.82 POLYMYOSITIS | 1 0.01 78.83 POLYNEUROPATHY | 3 0.03 78.86 POLYP | 3 0.03 78.89 POLYURIA | 1 0.01 78.90 POOR QUALITY DRUG ADMINISTERED | 2 0.02 78.92 POOR QUALITY SLEEP | 2 0.02 78.94 POOR VENOUS ACCESS | 2 0.02 78.96 PORTAL HYPERTENSION | 1 0.01 78.97 PORTAL VEIN THROMBOSIS | 1 0.01 78.98 PORTAL VENOUS GAS | 1 0.01 78.99 POST CHOLECYSTECTOMY SYNDROME | 2 0.02 79.01 POST CONCUSSION SYNDROME | 1 0.01 79.02 POST GASTRIC SURGERY SYNDROME | 1 0.01 79.03 POST HERPETIC NEURALGIA | 1 0.01 79.04 POST LAMINECTOMY SYNDROME | 1 0.01 79.05 POST PROCEDURAL COMPLICATION | 1 0.01 79.06 POST PROCEDURAL DISCHARGE | 1 0.01 79.07 POST PROCEDURAL HAEMORRHAGE | 2 0.02 79.09 POST PROCEDURAL INFECTION | 1 0.01 79.10 POST THROMBOTIC SYNDROME | 1 0.01 79.11 POST-TRAUMATIC AMNESTIC DISORDER | 1 0.01 79.12 POST-TRAUMATIC STRESS DISORDER | 1 0.01 79.13 POST-TUSSIVE VOMITING | 1 0.01 79.14 POSTERIOR REVERSIBLE ENCEPHALOPATHY S.. | 1 0.01 79.15 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 79.16 POSTURE ABNORMAL | 1 0.01 79.17 PRE-ECLAMPSIA | 1 0.01 79.18 PREGNANCY | 4 0.04 79.22 PREGNANCY ON ORAL CONTRACEPTIVE | 2 0.02 79.24 PREGNANCY WITH CONTRACEPTIVE DEVICE | 2 0.02 79.26 PREGNANCY WITH CONTRACEPTIVE PATCH | 1 0.01 79.27 PREMATURE BABY | 8 0.08 79.35 PREMATURE LABOUR | 6 0.06 79.41 PREMATURE MENOPAUSE | 1 0.01 79.42 PREMATURE RUPTURE OF MEMBRANES | 2 0.02 79.44 PREMENSTRUAL SYNDROME | 1 0.01 79.45 PRESYNCOPE | 3 0.03 79.48 PRIMARY SEQUESTRUM | 3 0.03 79.51 PRINZMETAL ANGINA | 1 0.01 79.52 PROCEDURAL COMPLICATION | 2 0.02 79.54 PROCEDURAL PAIN | 1 0.01 79.55 PROCTALGIA | 1 0.01 79.56 PROCTITIS | 1 0.01 79.57 PRODUCT ADHESION ISSUE | 11 0.11 79.68 PRODUCT COLOUR ISSUE | 1 0.01 79.69 PRODUCT CONTAMINATION MICROBIAL | 1 0.01 79.70 PRODUCT FORMULATION ISSUE | 3 0.03 79.73 PRODUCT LABEL ISSUE | 2 0.02 79.75 PRODUCT OUTER PACKAGING ISSUE | 1 0.01 79.76 PRODUCT QUALITY ISSUE | 24 0.24 80.00 PRODUCT SUBSTITUTION ISSUE | 2 0.02 80.02 PRODUCT TASTE ABNORMAL | 2 0.02 80.04 PRODUCTIVE COUGH | 8 0.08 80.12 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 7 0.07 80.19 PROSTATE CANCER | 1 0.01 80.20 PROSTATE CANCER STAGE I | 1 0.01 80.21 PROSTATE CANCER STAGE IV | 1 0.01 80.22 PROSTATECTOMY | 1 0.01 80.23 PROSTATIC CYST | 1 0.01 80.24 PROSTATIC DISORDER | 1 0.01 80.25 PROSTATIC SPECIFIC ANTIGEN DECREASED | 1 0.01 80.26 PROSTATIC SPECIFIC ANTIGEN INCREASED | 2 0.02 80.28 PROSTATOMEGALY | 1 0.01 80.29 PROTEIN URINE | 1 0.01 80.30 PROTEIN URINE PRESENT | 1 0.01 80.31 PROTEINURIA | 4 0.04 80.35 PROTHROMBIN LEVEL DECREASED | 1 0.01 80.36 PROTHROMBIN LEVEL INCREASED | 2 0.02 80.38 PROTHROMBIN TIME PROLONGED | 2 0.02 80.40 PROTHROMBIN TIME SHORTENED | 2 0.02 80.42 PRURITUS | 33 0.33 80.75 PRURITUS GENERALISED | 4 0.04 80.79 PSEUDOMEMBRANOUS COLITIS | 1 0.01 80.80 PSEUDOMONAL SEPSIS | 1 0.01 80.81 PSEUDOMONAS INFECTION | 2 0.02 80.83 PSOAS ABSCESS | 1 0.01 80.84 PSORIASIS | 6 0.06 80.90 PSORIATIC ARTHROPATHY | 3 0.03 80.93 PSYCHIATRIC SYMPTOM | 1 0.01 80.94 PSYCHOMOTOR RETARDATION | 1 0.01 80.95 PSYCHOTIC DISORDER | 7 0.07 81.02 PULMONARY ALVEOLAR HAEMORRHAGE | 1 0.01 81.03 PULMONARY ARTERIAL HYPERTENSION | 3 0.03 81.06 PULMONARY ARTERY STENOSIS CONGENITAL | 3 0.03 81.09 PULMONARY CONGESTION | 7 0.07 81.16 PULMONARY EMBOLISM | 46 0.46 81.62 PULMONARY FUNCTION TEST DECREASED | 1 0.01 81.63 PULMONARY HAEMORRHAGE | 6 0.06 81.69 PULMONARY HYPERTENSION | 5 0.05 81.74 PULMONARY INFARCTION | 3 0.03 81.77 PULMONARY MASS | 1 0.01 81.78 PULMONARY MYCOSIS | 1 0.01 81.79 PULMONARY OEDEMA | 4 0.04 81.83 PULMONARY THROMBOSIS | 3 0.03 81.86 PULMONARY TOXICITY | 1 0.01 81.87 PULMONARY VALVE STENOSIS CONGENITAL | 2 0.02 81.89 PULMONARY VENO-OCCLUSIVE DISEASE | 1 0.01 81.90 PULSE PRESSURE DECREASED | 1 0.01 81.91 PULSELESS ELECTRICAL ACTIVITY | 3 0.03 81.94 PUNCTATE KERATITIS | 2 0.02 81.96 PUPILLARY REFLEX IMPAIRED | 1 0.01 81.97 PURPURA | 2 0.02 81.99 PURULENT DISCHARGE | 2 0.02 82.01 PYELONEPHRITIS | 1 0.01 82.02 PYLORIC STENOSIS | 1 0.01 82.03 PYODERMA GANGRENOSUM | 1 0.01 82.04 PYOTHORAX | 1 0.01 82.05 PYREXIA | 78 0.78 82.83 QUALITY OF LIFE DECREASED | 2 0.02 82.85 RADICAL HYSTERECTOMY | 1 0.01 82.86 RADICULITIS | 1 0.01 82.87 RALES | 1 0.01 82.88 RASH | 51 0.51 83.39 RASH ERYTHEMATOUS | 8 0.08 83.47 RASH GENERALISED | 4 0.04 83.51 RASH MACULAR | 3 0.03 83.54 RASH MACULO-PAPULAR | 9 0.09 83.63 RASH MORBILLIFORM | 1 0.01 83.64 RASH PAPULAR | 2 0.02 83.66 RASH PRURITIC | 2 0.02 83.68 RASH PUSTULAR | 5 0.05 83.73 RASH SCARLATINIFORM | 1 0.01 83.74 RASH VESICULAR | 2 0.02 83.76 REACTION TO COLOURING | 1 0.01 83.77 REBOUND EFFECT | 1 0.01 83.78 RECTAL HAEMORRHAGE | 10 0.10 83.88 RED BLOOD CELL COUNT DECREASED | 5 0.05 83.93 RED BLOOD CELL COUNT INCREASED | 1 0.01 83.94 RED BLOOD CELL SEDIMENTATION RATE INC.. | 3 0.03 83.97 RED CELL DISTRIBUTION WIDTH INCREASED | 2 0.02 83.99 REFUSAL OF TREATMENT BY PATIENT | 3 0.03 84.02 RENAL APLASIA | 1 0.01 84.03 RENAL ARTERY STENOSIS | 1 0.01 84.04 RENAL ATROPHY | 1 0.01 84.05 RENAL COLIC | 2 0.02 84.07 RENAL CYST | 2 0.02 84.09 RENAL CYST HAEMORRHAGE | 2 0.02 84.11 RENAL DISORDER | 11 0.11 84.22 RENAL FAILURE | 31 0.31 84.53 RENAL FAILURE ACUTE | 43 0.43 84.96 RENAL FAILURE CHRONIC | 7 0.07 85.03 RENAL FAILURE NEONATAL | 1 0.01 85.04 RENAL FUNCTION TEST ABNORMAL | 1 0.01 85.05 RENAL IMPAIRMENT | 12 0.12 85.17 RENAL INJURY | 1 0.01 85.18 RENAL MASS | 1 0.01 85.19 RENAL STONE REMOVAL | 1 0.01 85.20 RENAL TRANSPLANT | 1 0.01 85.21 RENAL TUBULAR ACIDOSIS | 1 0.01 85.22 RENAL TUBULAR NECROSIS | 2 0.02 85.24 RESPIRATORY ARREST | 4 0.04 85.28 RESPIRATORY DEPRESSION | 1 0.01 85.29 RESPIRATORY DISORDER | 5 0.05 85.34 RESPIRATORY DISTRESS | 7 0.07 85.41 RESPIRATORY FAILURE | 25 0.25 85.66 RESPIRATORY RATE DECREASED | 1 0.01 85.67 RESPIRATORY THERAPY | 1 0.01 85.68 RESPIRATORY TRACT CONGESTION | 4 0.04 85.72 RESPIRATORY TRACT INFECTION | 4 0.04 85.76 RESPIRATORY TRACT IRRITATION | 1 0.01 85.77 RESTLESS LEGS SYNDROME | 3 0.03 85.80 RESTLESSNESS | 4 0.04 85.84 RESUSCITATION | 2 0.02 85.86 RETCHING | 3 0.03 85.89 RETICULOCYTE COUNT DECREASED | 2 0.02 85.91 RETINAL DETACHMENT | 3 0.03 85.94 RETINAL HAEMORRHAGE | 5 0.05 85.99 RETINAL TOXICITY | 1 0.01 86.00 RETINAL VASCULAR THROMBOSIS | 1 0.01 86.01 RETINAL VEIN OCCLUSION | 1 0.01 86.02 RETINOIC ACID SYNDROME | 1 0.01 86.03 RETINOPATHY OF PREMATURITY | 1 0.01 86.04 RETROPERITONEAL HAEMORRHAGE | 2 0.02 86.06 RETROPERITONEAL LYMPHADENOPATHY | 1 0.01 86.07 RHABDOMYOLYSIS | 16 0.16 86.23 RHEUMATOID ARTHRITIS | 9 0.09 86.32 RHINITIS | 1 0.01 86.33 RHINITIS ALLERGIC | 1 0.01 86.34 RHINOPLASTY | 1 0.01 86.35 RHINORRHOEA | 5 0.05 86.40 RHINOVIRUS INFECTION | 1 0.01 86.41 RHONCHI | 1 0.01 86.42 RIB FRACTURE | 3 0.03 86.45 RIGHT VENTRICULAR FAILURE | 1 0.01 86.46 ROAD TRAFFIC ACCIDENT | 9 0.09 86.55 ROTATOR CUFF SYNDROME | 12 0.12 86.67 SACROILIITIS | 1 0.01 86.68 SALIVARY GLAND CANCER | 1 0.01 86.69 SALIVARY HYPERSECRETION | 2 0.02 86.71 SARCOIDOSIS | 3 0.03 86.74 SARCOMA | 1 0.01 86.75 SCAR | 2 0.02 86.77 SCIATIC NERVE INJURY | 1 0.01 86.78 SCIATICA | 3 0.03 86.81 SCLERAL DISCOLOURATION | 1 0.01 86.82 SCLERODERMA | 1 0.01 86.83 SCRATCH | 2 0.02 86.85 SCREAMING | 1 0.01 86.86 SCROTAL DISORDER | 1 0.01 86.87 SEBORRHOEIC DERMATITIS | 1 0.01 86.88 SECONDARY HYPERTENSION | 1 0.01 86.89 SEDATION | 4 0.04 86.93 SELF INJURIOUS BEHAVIOUR | 3 0.03 86.96 SELF-MEDICATION | 3 0.03 86.99 SEMEN VISCOSITY ABNORMAL | 1 0.01 87.00 SENSATION OF HEAVINESS | 1 0.01 87.01 SENSE OF OPPRESSION | 3 0.03 87.04 SENSORY DISTURBANCE | 5 0.05 87.09 SENSORY LOSS | 2 0.02 87.11 SEPSIS | 30 0.30 87.41 SEPTIC SHOCK | 8 0.08 87.49 SERONEGATIVE ARTHRITIS | 1 0.01 87.50 SEROTONIN SYNDROME | 1 0.01 87.51 SERUM FERRITIN DECREASED | 1 0.01 87.52 SERUM FERRITIN INCREASED | 2 0.02 87.54 SERUM SICKNESS | 1 0.01 87.55 SEXUAL DYSFUNCTION | 2 0.02 87.57 SHOCK | 4 0.04 87.61 SHOULDER ARTHROPLASTY | 1 0.01 87.62 SICK SINUS SYNDROME | 2 0.02 87.64 SICKLE CELL ANAEMIA WITH CRISIS | 1 0.01 87.65 SIMPLE PARTIAL SEIZURES | 1 0.01 87.66 SINGLE UMBILICAL ARTERY | 1 0.01 87.67 SINOATRIAL BLOCK | 1 0.01 87.68 SINUS ARREST | 1 0.01 87.69 SINUS ARRHYTHMIA | 1 0.01 87.70 SINUS CONGESTION | 2 0.02 87.72 SINUS DISORDER | 3 0.03 87.75 SINUS HEADACHE | 1 0.01 87.76 SINUS TACHYCARDIA | 1 0.01 87.77 SINUS TARSI SYNDROME | 2 0.02 87.79 SINUSITIS | 14 0.14 87.93 SJOGREN'S SYNDROME | 1 0.01 87.94 SKIN ATROPHY | 2 0.02 87.96 SKIN BURNING SENSATION | 1 0.01 87.97 SKIN CANCER | 2 0.02 87.99 SKIN DEPIGMENTATION | 1 0.01 88.00 SKIN DISCOLOURATION | 8 0.08 88.08 SKIN DISORDER | 3 0.03 88.11 SKIN EROSION | 1 0.01 88.12 SKIN EXFOLIATION | 5 0.05 88.17 SKIN FISSURES | 1 0.01 88.18 SKIN HAEMORRHAGE | 2 0.02 88.20 SKIN HYPERPIGMENTATION | 1 0.01 88.21 SKIN HYPERTROPHY | 2 0.02 88.23 SKIN HYPOPIGMENTATION | 1 0.01 88.24 SKIN INFECTION | 1 0.01 88.25 SKIN INJURY | 1 0.01 88.26 SKIN LESION | 2 0.02 88.28 SKIN LESION EXCISION | 1 0.01 88.29 SKIN NECROSIS | 3 0.03 88.32 SKIN NEOPLASM EXCISION | 1 0.01 88.33 SKIN ODOUR ABNORMAL | 1 0.01 88.34 SKIN OEDEMA | 1 0.01 88.35 SKIN PLAQUE | 1 0.01 88.36 SKIN SWELLING | 1 0.01 88.37 SKIN TEST NEGATIVE | 1 0.01 88.38 SKIN ULCER | 6 0.06 88.44 SKULL FRACTURE | 1 0.01 88.45 SLEEP APNOEA SYNDROME | 1 0.01 88.46 SLEEP DISORDER | 7 0.07 88.53 SLEEP TALKING | 1 0.01 88.54 SLUGGISHNESS | 4 0.04 88.58 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 1 0.01 88.59 SMALL FOR DATES BABY | 3 0.03 88.62 SMALL INTESTINAL OBSTRUCTION | 4 0.04 88.66 SMEAR CERVIX ABNORMAL | 1 0.01 88.67 SNEEZING | 1 0.01 88.68 SNORING | 1 0.01 88.69 SOMATOFORM DISORDER | 1 0.01 88.70 SOMNOLENCE | 24 0.24 88.94 SOPOR | 1 0.01 88.95 SPASMODIC DYSPHONIA | 1 0.01 88.96 SPEECH DISORDER | 6 0.06 89.02 SPINA BIFIDA | 1 0.01 89.03 SPINAL COLUMN INJURY | 1 0.01 89.04 SPINAL COLUMN STENOSIS | 1 0.01 89.05 SPINAL COMPRESSION FRACTURE | 4 0.04 89.09 SPINAL CORD DISORDER | 1 0.01 89.10 SPINAL DEFORMITY | 1 0.01 89.11 SPINAL DISORDER | 1 0.01 89.12 SPINAL FRACTURE | 6 0.06 89.18 SPINAL FUSION SURGERY | 1 0.01 89.19 SPINAL LAMINECTOMY | 1 0.01 89.20 SPINAL OPERATION | 1 0.01 89.21 SPINAL OSTEOARTHRITIS | 1 0.01 89.22 SPLEEN DISORDER | 1 0.01 89.23 SPLENECTOMY | 2 0.02 89.25 SPLENIC CYST | 1 0.01 89.26 SPLENOMEGALY | 6 0.06 89.32 SPUTUM DISCOLOURED | 3 0.03 89.35 SPUTUM RETENTION | 1 0.01 89.36 SQUAMOUS CELL CARCINOMA | 2 0.02 89.38 SQUAMOUS CELL CARCINOMA OF SKIN | 1 0.01 89.39 STAPHYLOCOCCAL INFECTION | 11 0.11 89.50 STAPHYLOCOCCAL SEPSIS | 2 0.02 89.52 STARING | 1 0.01 89.53 STATUS EPILEPTICUS | 2 0.02 89.55 STEM CELL TRANSPLANT | 2 0.02 89.57 STENT PLACEMENT | 4 0.04 89.61 STEVENS-JOHNSON SYNDROME | 7 0.07 89.68 STILLBIRTH | 2 0.02 89.70 STOMATITIS | 11 0.11 89.81 STRABISMUS | 3 0.03 89.84 STREPTOCOCCAL INFECTION | 1 0.01 89.85 STRESS | 8 0.08 89.93 STRESS URINARY INCONTINENCE | 1 0.01 89.94 STUPOR | 1 0.01 89.95 SUBACUTE HEPATIC FAILURE | 1 0.01 89.96 SUBARACHNOID HAEMORRHAGE | 1 0.01 89.97 SUBCLAVIAN ARTERY THROMBOSIS | 1 0.01 89.98 SUBCLAVIAN VEIN THROMBOSIS | 1 0.01 89.99 SUBCUTANEOUS ABSCESS | 1 0.01 90.00 SUBDURAL HAEMATOMA | 3 0.03 90.03 SUBDURAL HAEMORRHAGE | 1 0.01 90.04 SUBILEUS | 2 0.02 90.06 SUBSTANCE ABUSE | 1 0.01 90.07 SUDDEN DEATH | 2 0.02 90.09 SUFFOCATION FEELING | 3 0.03 90.12 SUICIDAL IDEATION | 15 0.15 90.27 SUICIDE ATTEMPT | 13 0.13 90.40 SUPERINFECTION | 4 0.04 90.44 SUPERIOR SAGITTAL SINUS THROMBOSIS | 1 0.01 90.45 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 90.46 SUPRAVENTRICULAR TACHYCARDIA | 4 0.04 90.50 SURGERY | 18 0.18 90.68 SWEAT GLAND DISORDER | 1 0.01 90.69 SWELLING | 13 0.13 90.82 SWELLING FACE | 8 0.08 90.90 SWOLLEN TONGUE | 6 0.06 90.96 SYNCOPE | 19 0.19 91.15 SYNOVIAL CYST | 2 0.02 91.17 SYNOVIAL RUPTURE | 1 0.01 91.18 SYNOVITIS | 2 0.02 91.20 SYRINGE ISSUE | 1 0.01 91.21 SYSTEMIC LUPUS ERYTHEMATOSUS | 1 0.01 91.22 TACHYARRHYTHMIA | 1 0.01 91.23 TACHYCARDIA | 15 0.15 91.38 TACHYCARDIA PAROXYSMAL | 1 0.01 91.39 TACHYPNOEA | 2 0.02 91.41 TALIPES | 1 0.01 91.42 TARDIVE DYSKINESIA | 2 0.02 91.44 TEARFULNESS | 2 0.02 91.46 TEMPORAL LOBE EPILEPSY | 1 0.01 91.47 TENDERNESS | 2 0.02 91.49 TENDON DISORDER | 1 0.01 91.50 TENDON INJURY | 1 0.01 91.51 TENDON PAIN | 2 0.02 91.53 TENDON RUPTURE | 12 0.12 91.65 TENDONITIS | 7 0.07 91.72 TENOSYNOVITIS | 5 0.05 91.77 TENSION | 1 0.01 91.78 TERATOGENICITY | 1 0.01 91.79 TERATOMA | 1 0.01 91.80 TERMINAL STATE | 8 0.08 91.88 TESTICULAR DISORDER | 1 0.01 91.89 TESTICULAR PAIN | 1 0.01 91.90 TESTICULAR SWELLING | 1 0.01 91.91 THERAPEUTIC PROCEDURE | 1 0.01 91.92 THERAPEUTIC RESPONSE DECREASED | 5 0.05 91.97 THERAPEUTIC RESPONSE UNEXPECTED | 2 0.02 91.99 THINKING ABNORMAL | 4 0.04 92.03 THIRST | 1 0.01 92.04 THORACIC CAVITY DRAINAGE | 1 0.01 92.05 THROAT TIGHTNESS | 2 0.02 92.07 THROMBOCYTOPENIA | 29 0.29 92.36 THROMBOCYTOSIS | 3 0.03 92.39 THROMBOPHLEBITIS | 1 0.01 92.40 THROMBOSIS | 18 0.18 92.58 THROMBOSIS IN DEVICE | 2 0.02 92.60 THROMBOTIC MICROANGIOPATHY | 2 0.02 92.62 THROMBOTIC THROMBOCYTOPENIC PURPURA | 2 0.02 92.64 THYMOMA | 1 0.01 92.65 THYROID CANCER | 1 0.01 92.66 THYROID CYST | 1 0.01 92.67 THYROID DISORDER | 2 0.02 92.69 THYROID MASS | 1 0.01 92.70 THYROID NEOPLASM | 4 0.04 92.74 THYROIDITIS | 1 0.01 92.75 TIBIA FRACTURE | 4 0.04 92.79 TIC | 1 0.01 92.80 TINEA MANUUM | 1 0.01 92.81 TINNITUS | 4 0.04 92.85 TOBACCO USER | 2 0.02 92.87 TONGUE BLISTERING | 1 0.01 92.88 TONGUE NEOPLASM | 1 0.01 92.89 TONGUE ULCERATION | 1 0.01 92.90 TONIC CONVULSION | 1 0.01 92.91 TONSILLAR DISORDER | 1 0.01 92.92 TONSILLECTOMY | 1 0.01 92.93 TONSILLITIS | 1 0.01 92.94 TOOTH ABSCESS | 3 0.03 92.97 TOOTH DISORDER | 4 0.04 93.01 TOOTH EXTRACTION | 6 0.06 93.07 TOOTH FRACTURE | 1 0.01 93.08 TOOTH HYPOPLASIA | 1 0.01 93.09 TOOTH IMPACTED | 1 0.01 93.10 TOOTH INFECTION | 4 0.04 93.14 TOOTH LOSS | 1 0.01 93.15 TOOTHACHE | 1 0.01 93.16 TORSADE DE POINTES | 4 0.04 93.20 TORTICOLLIS | 1 0.01 93.21 TOTAL LUNG CAPACITY DECREASED | 1 0.01 93.22 TOXIC EPIDERMAL NECROLYSIS | 4 0.04 93.26 TOXIC SKIN ERUPTION | 4 0.04 93.30 TOXICITY TO VARIOUS AGENTS | 49 0.49 93.79 TOXOPLASMOSIS | 1 0.01 93.80 TRACHEOSTOMY | 1 0.01 93.81 TRANSAMINASES INCREASED | 8 0.08 93.89 TRANSFUSION | 3 0.03 93.92 TRANSFUSION REACTION | 1 0.01 93.93 TRANSFUSION-RELATED ACUTE LUNG INJURY | 1 0.01 93.94 TRANSIENT GLOBAL AMNESIA | 1 0.01 93.95 TRANSIENT ISCHAEMIC ATTACK | 10 0.10 94.05 TRANSPLANT REJECTION | 5 0.05 94.10 TRANSPOSITION OF THE GREAT VESSELS | 1 0.01 94.11 TRAUMATIC BRAIN INJURY | 1 0.01 94.12 TRAUMATIC INTRACRANIAL HAEMORRHAGE | 1 0.01 94.13 TREATMENT FAILURE | 1 0.01 94.14 TREATMENT NONCOMPLIANCE | 11 0.11 94.25 TREMOR | 20 0.20 94.45 TRICUSPID VALVE DISEASE | 1 0.01 94.46 TRICUSPID VALVE INCOMPETENCE | 1 0.01 94.47 TRISMUS | 1 0.01 94.48 TROPONIN I INCREASED | 2 0.02 94.50 TROPONIN INCREASED | 3 0.03 94.53 TROPONIN T INCREASED | 1 0.01 94.54 TUBERCULOSIS | 2 0.02 94.56 TUBERCULOUS PLEURISY | 1 0.01 94.57 TUBULOINTERSTITIAL NEPHRITIS | 7 0.07 94.64 TUMOUR EXCISION | 5 0.05 94.69 TUMOUR HAEMORRHAGE | 1 0.01 94.70 TUMOUR INVASION | 1 0.01 94.71 TUMOUR LYSIS SYNDROME | 2 0.02 94.73 TUNNEL VISION | 1 0.01 94.74 TYPE 2 DIABETES MELLITUS | 3 0.03 94.77 ULCER | 2 0.02 94.79 ULCER HAEMORRHAGE | 1 0.01 94.80 UMBILICAL HERNIA | 1 0.01 94.81 UNEVALUABLE EVENT | 7 0.07 94.88 UNINTENDED PREGNANCY | 2 0.02 94.90 UNRESPONSIVE TO STIMULI | 7 0.07 94.97 UPPER GASTROINTESTINAL HAEMORRHAGE | 3 0.03 95.00 UPPER LIMB FRACTURE | 2 0.02 95.02 UPPER RESPIRATORY TRACT INFECTION | 6 0.06 95.08 UPPER-AIRWAY COUGH SYNDROME | 1 0.01 95.09 URETERECTOMY | 1 0.01 95.10 URETERIC OBSTRUCTION | 1 0.01 95.11 URETHRAL CARUNCLE | 1 0.01 95.12 URETHRAL OBSTRUCTION | 1 0.01 95.13 URINARY CASTS PRESENT | 1 0.01 95.14 URINARY CYSTECTOMY | 1 0.01 95.15 URINARY HESITATION | 2 0.02 95.17 URINARY INCONTINENCE | 3 0.03 95.20 URINARY RETENTION | 6 0.06 95.26 URINARY TRACT DISORDER | 1 0.01 95.27 URINARY TRACT INFECTION | 24 0.24 95.51 URINARY TRACT INFECTION FUNGAL | 1 0.01 95.52 URINARY TRACT OBSTRUCTION | 1 0.01 95.53 URINE ABNORMALITY | 1 0.01 95.54 URINE ALBUMIN/CREATININE RATIO INCREA.. | 2 0.02 95.56 URINE COLOUR ABNORMAL | 1 0.01 95.57 URINE OUTPUT DECREASED | 1 0.01 95.58 URINE OUTPUT INCREASED | 1 0.01 95.59 URINE SODIUM INCREASED | 1 0.01 95.60 UROSEPSIS | 2 0.02 95.62 URTICARIA | 23 0.23 95.85 UTERINE CANCER | 1 0.01 95.86 UTERINE DISORDER | 1 0.01 95.87 UTERINE LEIOMYOMA | 2 0.02 95.89 UTERINE PERFORATION | 1 0.01 95.90 UTERINE POLYP | 1 0.01 95.91 UTERINE PROLAPSE | 1 0.01 95.92 VAGINAL DISCHARGE | 1 0.01 95.93 VAGINAL HAEMORRHAGE | 11 0.11 96.04 VAGINAL INFECTION | 2 0.02 96.06 VAGINITIS BACTERIAL | 1 0.01 96.07 VARICELLA | 2 0.02 96.09 VASCULAR CALCIFICATION | 3 0.03 96.12 VASCULAR COMPRESSION | 1 0.01 96.13 VASCULAR GRAFT | 3 0.03 96.16 VASCULAR INSUFFICIENCY | 1 0.01 96.17 VASCULAR PURPURA | 1 0.01 96.18 VASCULAR RUPTURE | 1 0.01 96.19 VASCULITIC RASH | 1 0.01 96.20 VASCULITIS | 1 0.01 96.21 VASCULITIS CEREBRAL | 1 0.01 96.22 VASOCONSTRICTION | 1 0.01 96.23 VEIN DISORDER | 2 0.02 96.25 VEIN PAIN | 1 0.01 96.26 VENA CAVA INJURY | 1 0.01 96.27 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 96.28 VENOUS OCCLUSION | 1 0.01 96.29 VENOUS THROMBOSIS | 1 0.01 96.30 VENOUS THROMBOSIS LIMB | 3 0.03 96.33 VENTRICULAR ARRHYTHMIA | 1 0.01 96.34 VENTRICULAR DYSFUNCTION | 2 0.02 96.36 VENTRICULAR EXTRASYSTOLES | 1 0.01 96.37 VENTRICULAR FIBRILLATION | 3 0.03 96.40 VENTRICULAR HYPERTROPHY | 1 0.01 96.41 VENTRICULAR HYPOKINESIA | 1 0.01 96.42 VENTRICULAR SEPTAL DEFECT | 12 0.12 96.54 VENTRICULAR TACHYCARDIA | 6 0.06 96.60 VERTIGO | 13 0.13 96.73 VERTIGO POSITIONAL | 1 0.01 96.74 VESICOURETERIC REFLUX | 1 0.01 96.75 VESTIBULAR NEURONITIS | 1 0.01 96.76 VIITH NERVE PARALYSIS | 4 0.04 96.80 VIRAL INFECTION | 2 0.02 96.82 VIRAL LOAD | 1 0.01 96.83 VIROLOGIC FAILURE | 2 0.02 96.85 VISION BLURRED | 25 0.25 97.10 VISUAL ACUITY REDUCED | 19 0.19 97.29 VISUAL FIELD DEFECT | 1 0.01 97.30 VISUAL IMPAIRMENT | 19 0.19 97.49 VISUAL PATHWAY DISORDER | 1 0.01 97.50 VITAL FUNCTIONS ABNORMAL | 1 0.01 97.51 VITAMIN D DEFICIENCY | 2 0.02 97.53 VITRECTOMY | 1 0.01 97.54 VITREOUS FLOATERS | 1 0.01 97.55 VITREOUS HAEMORRHAGE | 1 0.01 97.56 VITRITIS | 2 0.02 97.58 VOMITING | 78 0.78 98.36 VULVOVAGINAL MYCOTIC INFECTION | 2 0.02 98.38 VULVOVAGINAL PRURITUS | 1 0.01 98.39 WALKING AID USER | 2 0.02 98.41 WALKING DISABILITY | 1 0.01 98.42 WEANING FAILURE | 1 0.01 98.43 WEGENER'S GRANULOMATOSIS | 1 0.01 98.44 WEIGHT BEARING DIFFICULTY | 1 0.01 98.45 WEIGHT DECREASED | 41 0.41 98.86 WEIGHT INCREASED | 26 0.26 99.12 WHEELCHAIR USER | 2 0.02 99.14 WHEEZING | 13 0.13 99.27 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.28 WHITE BLOOD CELL COUNT DECREASED | 15 0.15 99.43 WHITE BLOOD CELL COUNT INCREASED | 6 0.06 99.49 WHITE BLOOD CELLS STOOL | 1 0.01 99.50 WITHDRAWAL SYNDROME | 11 0.11 99.61 WOUND | 1 0.01 99.62 WOUND INFECTION | 2 0.02 99.64 WOUND TREATMENT | 1 0.01 99.65 WRIST FRACTURE | 4 0.04 99.69 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 25 0.25 99.94 XEROSIS | 1 0.01 99.95 XXYY SYNDROME | 2 0.02 99.97 YELLOW SKIN | 2 0.02 99.99 ZYGOMYCOSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015